Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Brunner Thomas Baptist |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2025
Originalarbeit (Zeitschrift)
** Bitzer, M; Gross, S; Albert, J; Blödt, S; Boda-Heggemann, J; Borucki, K; Brunner, T; Caspari, R; Dombrowski, F; Evert, M; Follmann, M; Freudenberger, P; Gani, C; Gebert, J; Geier, A; Gkika, E; Götz, M; Helmberger, T; Hoffmann, RT; Huppert, P; Krug, D; La Fougère, C; Lang, HK; Langer, T; Lenz, P; Lüdde, T; Mahnken, A; Nadalin, S; Nguyen, HHP; Nothacker, M; Ockenga, J; Oldhafer, K; Ott, J; Paprottka, P; Pereira, P; Persigehl, T; Plentz, R; Pohl, J; Recken, H; Reimer, P; Riemer, J; Ringe, K; Roeb, E; Rüssel, J; Schellhaas, B; Schirmacher, P; Schlitt, HJ; Schmid, I; Schütte, K; Schuler, A; Seehofer, D; Sinn, M; Stengel, A; Steubesand, N; Stoll, C; Tannapfel, A; Taubert, A; Trojan, J; van Thiel, I; Utzig, M; Vogel, A; Vogl, T; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wenzel, G; Wildner, D; Wörns, MA; Galle, P; Malek, N
S3 Guideline Diagnostics and Therapy of Hepatocellular Carcinoma - Short Version
Z GASTROENTEROL. 2025; 63(03): 293-336.
Doi: 10.1055/a-2446-2408
Web of Science
PubMed
FullText
FullText_MUG
** Dapper, H; Fleischmann, M; Tselis, N; Diefenhardt, M; Hofheinz, RD; Weiß, C; Grabenbauer, GG; Merten, R; Grosu, AL; Kirste, S; Rieken, S; Claßen, J; Langer, C; Kuhnt, T; Schmidberger, H; Ghadimi, M; Giordano, F; Nestle, U; Koerber, SA; Bock, F; Geiger, M; Polat, B; Bruns, CJ; Dieplinger, G; Popp, F; Zander, T; Brunner, T; Tribius, S; Arnold, D; Wurschi, G; Piso, P; Friede, T; Hörner-Rieber, J; Gkika, E; Rödel, C; Fokas, E, , German, Rectal, Cancer, Study, Group
ACO/ARO/AIO-22 - External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group.
Clin Transl Radiat Oncol. 2025; 53:100958
Doi: 10.1016/j.ctro.2025.100958
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gross, S; Bitzer, M; Albert, J; Blödt, S; Boda-Heggemann, J; Borucki, K; Brunner, T; Caspari, R; Dombrowski, F; Evert, M; Follmann, M; Freudenberger, P; Gani, C; Gebert, J; Geier, A; Gkika, E; Götz, M; Helmberger, T; Hoffmann, RT; Huppert, P; Krug, D; La Fougère, C; Lang, H; Langer, T; Lenz, P; Lüdde, T; Mahnken, A; Nadalin, S; Nguyen, HHP; Nothacker, M; Ockenga, J; Oldhafer, K; Ott, J; Paprottka, P; Pereira, P; Persigehl, T; Plentz, R; Pohl, J; Recken, H; Reimer, P; Riemer, J; Ringe, K; Roeb, E; Rüssel, J; Schellhaas, B; Schirmacher, P; Schlitt, HJ; Schmid, I; Schütte, K; Schuler, A; Seehofer, D; Sinn, M; Stengel, A; Steubesand, N; Stoll, C; Tannapfel, A; Taubert, A; Trojan, J; van Thiel, I; Utzig, M; Vogel, A; Vogl, T; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wenzel, G; Wildner, D; Wörns, MA; Galle, P; Malek, N
S3 Guideline for the Diagnosis and Treatment of biliary Carcinomas - Short Version Version 5.1-August 2024-AWMF Registration Number: 032-053OL
Z GASTROENTEROL. 2025; 63(2): 169-203.
Doi: 10.1055/a-2446-2454
Web of Science
PubMed
FullText
FullText_MUG
** Hoeppner, J; Brunner, T; Schmoor, C; Bronsert, P; Kulemann, B; Claus, R; Utzolino, S; Izbicki, JR; Gockel, I; Gerdes, B; Ghadimi, M; Reichert, B; Lock, JF; Bruns, C; Reitsamer, E; Schmeding, M; Benedix, F; Keck, T; Folprecht, G; Thuss-Patience, P; Neumann, UP; Pascher, A; Imhof, D; Daum, S; Strieder, T; Krautz, C; Zimmermann, S; Werner, J; Mahlberg, R; Illerhaus, G; Grimminger, P; Lordick, F
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer.
N Engl J Med. 2025; 392(4):323-335
Doi: 10.1056/NEJMoa2409408
Web of Science
PubMed
FullText
FullText_MUG
** Moustakis, C; Blanck, O; Grohmann, M; Albers, D; Bartels, D; Bathen, B; Borzì, GR; Broggi, S; Bruschi, A; Casale, M; Delana, A; Doolan, P; Tazehmahalleh, FE; Fabiani, S; Falco, MD; Fehr, R; Friedlein, M; Gutser, S; Hamada, A; Hancock, T; Köhn, J; Kornhuber, C; Krieger, T; Lambrecht, U; Lappi, S; Moretti, E; Mirus, A; Muedder, T; Plaude, S; Polvika, B; Ravaglia, V; Righetto, R; Rinaldin, G; Schachner, H; Scaggion, A; Schilling, P; Szeverinski, P; Villaggi, E; Walke, M; Wilke, L; Winkler, P; Nicolay, NH; Eich, HT; Gkika, E; Brunner, TB; Schmitt, D
Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas with Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery.
Int J Radiat Oncol Biol Phys. 2024;
Doi: 10.1016/j.ijrobp.2024.08.038
Web of Science
PubMed
FullText
FullText_MUG
** Nägler, F; Gleim, N; Seiler, I; Rühle, A; Hering, K; Seidel, C; Gkika, E; Krug, D; Blanck, O; Moustakis, C; Brunner, TB; Wittig-Sauerwein, A; Nicolay, NH
Stereotactic radiotherapy for spinal and non-spinal bone metastases: a patterns-of-care analysis in German-speaking countries as part of a project of the interdisciplinary Radiosurgery and Stereotactic Radiotherapy Working Group of the DEGRO/DGMP.
Strahlenther Onkol. 2025;
Doi: 10.1007/s00066-025-02387-y
Web of Science
PubMed
FullText
FullText_MUG
** Nägler, F; Vorbach, S; Mohamed, AA; Thaqi, S; Adebahr, S; Ehret, F; Kraft, J; Fabian, A; Weissmann, T; Kaufmann, J; Drabke, S; Looman, EL; Waltenberger, M; Kraus, KM; Grohmann, M; Dehl, K; Rogers, S; Gawish, A; Becker, JN; Klement, RJ; Partl, R; Trommer, M; Grosu, AL; Rimner, A; Gkika, E; Riesterer, O; Putz, F; Ganswindt, U; Moustakis, C; Nicolay, NH; Brunner, TB; Blanck, O; Wittig-Sauerwein, A; Balermpas, P; Rühle, A
Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
Int J Radiat Oncol Biol Phys. 2025;
Doi: 10.1016/j.ijrobp.2024.12.015
Web of Science
PubMed
FullText
FullText_MUG
** Xie, J; Bicu, AS; Grehn, M; Kuru, M; Zaman, A; Lu, X; Janorschke, C; van, der, Pol, LHG; Fast, MF; Fleckenstein, J; Both, M; Hohmann, S; Borzov, E; Winkler, P; Tilz, RR; Rades, D; Giordano, FA; Buergy, D; Rudic, B; Duncker, D; Merten, R; Charas, T; Suleiman, M; Brunner, T; Scherr, D; Lian, E; Schweikard, A; Blanck, O; Boda-Heggemann, J; Kaestner, L
Electrocardiogram-gated cardiac computed tomography-based patient- and segment-specific cardiac motion estimation method in stereotactic arrhythmia radioablation for ventricular tachycardia.
Phys Imaging Radiat Oncol. 2025; 33:100700
Doi: 10.1016/j.phro.2025.100700
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Gross, S; Bitzer, M; Albert, J; Blödt, S; Boda-Heggemann, J; Borucki, K; Brunner, T; Caspari, R; Dombrowski, F; Evert, M; Follmann, M; Freudenberger, P; Gani, C; Gebert, J; Geier, A; Gkika, E; Götz, M; Helmberger, T; Hoffmann, RT; Huppert, P; Krug, D; La Fougère, C; Lang, H; Langer, T; Lenz, P; Lüdde, T; Mahnken, A; Nadalin, S; Nguyen, HHP; Nothacker, M; Ockenga, J; Oldhafer, K; Ott, J; Paprottka, P; Pereira, P; Persigehl, T; Plentz, R; Pohl, J; Recken, H; Reimer, P; Riemer, J; Ringe, K; Roeb, E; Rüssel, J; Schellhaas, B; Schirmacher, P; Schlitt, HJ; Schmid, I; Schütte, K; Schuler, A; Seehofer, D; Sinn, M; Stengel, A; Steubesand, N; Stoll, C; Tannapfel, A; Taubert, A; Trojan, J; van Thiel, I; Utzig, M; Vogel, A; Vogl, T; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wenzel, G; Wildner, D; Wörns, MA; Galle, P; Malek, N
S3 Guideline for the Diagnosis and Treatment of biliary Carcinomas - Long Version Version 5.1-August 2024-AWMF Registry Number: 032-053OL
Z GASTROENTEROL. 2025; 63(02): e82-e158.
Doi: 10.1055/a-2460-6347
Web of Science
PubMed
FullText
FullText_MUG
2024
Originalarbeit (Zeitschrift)
** Bitzer, M; Gross, S; Albert, J; Blödt, S; Boda-Heggemann, J; Brunner, T; Caspari, R; De Toni, E; Dombrowski, F; Evert, M; Follmann, M; Freudenberger, P; Gani, C; Geier, A; Gkika, E; Götz, M; Helmberger, T; Hoffmann, RT; Huppert, P; Krug, D; La Fougère, C; Lang, H; Langer, T; Lenz, P; Lüdde, T; Mahnken, A; Nadalin, S; Nguyen, HHP; Nothacker, M; Ockenga, J; Oldhafer, K; Paprottka, P; Pereira, P; Persigehl, T; Plentz, R; Pohl, J; Recken, H; Reimer, P; Riemer, J; Ritterbusch, U; Roeb, E; Rüssel, J; Schellhaas, B; Schirmacher, P; Schlitt, HJ; Schmid, I; Schuler, A; Seehofer, D; Sinn, M; Stengel, A; Steubesand, N; Stoll, C; Tannapfel, A; Taubert, A; Tholen, R; Trojan, J; van Thiel, I; Vogel, A; Vogl, T; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wildner, D; Wörns, MA; Galle, P; Malek, N
S3 guideline "Diagnostics and treatment of biliary carcinomas" - short version
Z GASTROENTEROL. 2024; 62(02): 231-260.
Doi: 10.1055/a-2189-8826
Web of Science
PubMed
FullText
FullText_MUG
** Bitzer, M; Gross, S; Albert, J; Blödt, S; Boda-Heggemann, J; Brunner, T; Caspari, R; De Toni, E; Dombrowski, F; Evert, M; Follmann, M; Freudenberger, P; Gani, C; Geier, A; Gkika, E; Götz, M; Helmberger, T; Hoffmann, RT; Huppert, P; Krug, D; La Fougère, C; Lang, HK; Langer, T; Lenz, P; Lüdde, T; Mahnken, A; Nadalin, S; Nguyen, HHP; Nothacker, M; Ockenga, J; Oldhafer, K; Paprottka, P; Pereira, P; Persigehl, T; Plentz, R; Pohl, J; Recken, H; Reimer, P; Riemer, J; Ritterbusch, U; Roeb, E; Rüssel, J; Schellhaas, B; Schirmacher, P; Schlitt, HJ; Schmid, I; Schuler, A; Seehofer, D; Sinn, M; Stengel, A; Steubesand, N; Stoll, C; Tannapfel, A; Taubert, A; Tholen, R; Trojan, J; van Thiel, I; Vogel, A; Vogl, T; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wildner, D; Wörns, MA; Galle, P; Malek, N
S3 guideline "Diagnostics and therapy of hepatocellular carcinoma" - long version 4.0
Z GASTROENTEROL. 2024; 62(01): e67-e161.
Doi: 10.1055/a-2189-6353
Web of Science
PubMed
FullText
FullText_MUG
** Gross, S; Bitzer, M; Albert, J; Blödt, S; Boda-Heggemann, J; Brunner, T; Caspan, R; De Toni, E; Dombrowski, F; Evert, M; Follmann, M; Freudenberger, P; Gani, C; Geier, A; Gkika, E; Götz, M; Helmberger, T; Hoffmann, RT; Huppert, P; Krug, D; La Fougère, C; Lang, H; Langer, T; Lenz, P; Lüdde, T; Mahnken, A; Nadalin, S; Nguyen, HHP; Nothacker, M; Ockenga, J; Oldhafer, K; Paprottka, P; Pereira, P; Persigehl, T; Plentz, R; Pohl, J; Recken, H; Reimer, P; Riemer, J; Ritterbusch, U; Roeb, E; Rüssel, J; Schellhaas, B; Schirmacher, P; Schlitt, HJ; Schmid, I; Schuler, A; Seehofer, D; Sinn, M; Stengel, A; Steubesand, N; Stoll, C; Tannapfel, A; Taubert, A; Tholen, R; Trojan, J; van Thiel, I; Vogel, A; Vogl, T; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wildner, D; Wörns, MA; Galle, P; Malek, N
S3 guideline "Diagnostics and treatment of biliary carcinomas" - long version 4.0
Z GASTROENTEROL. 2024; 62(02): e213-e282.
Doi: 10.1055/a-2189-8567
Web of Science
PubMed
FullText
FullText_MUG
** Gross, S; Bitzer, M; Albert, J; Blödt, S; Boda-Heggemann, J; Brunner, T; Caspari, R; De Toni, E; Dombrowski, F; Evert, M; Follmann, M; Freudenberger, P; Gani, C; Geier, A; Gkika, E; Götz, M; Helmberger, T; Hoffmann, RT; Huppert, P; Krug, D; La Fougère, C; Lang, HK; Langer, T; Lenz, P; Lüdde, T; Mahnken, A; Nadalin, S; Nguyen, HHP; Nothacker, M; Ockenga, J; Oldhafer, K; Paprottka, P; Pereira, P; Persigehl, T; Plentz, R; Pohl, J; Recken, H; Reimer, P; Riemer, J; Ritterbusch, U; Roeb, E; Rüssel, J; Schellhaas, B; Schirmacher, P; Schlitt, HJ; Schmid, I; Schuler, A; Seehofer, D; Sinn, M; Stengel, A; Steubesand, N; Stoll, C; Tannapfel, A; Taubert, A; Tholen, R; Trojan, J; van Thiel, I; Vogel, A; Vogl, T; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wildner, D; Wörns, MA; Galle, P; Malek, N
S3 guideline "Diagnostics and therapy of hepatocellular carcinoma" - short version
Z GASTROENTEROL. 2024; 62(01): 73-109.
Doi: 10.1055/a-2189-8461
Web of Science
PubMed
FullText
FullText_MUG
** Hecht, M; Frey, B; Gaipl, US; Tianyu, X; Eckstein, M; Donaubauer, AJ; Klautke, G; Illmer, T; Fleischmann, M; Laban, S; Hautmann, MG; Tamaskovics, B; Brunner, TB; Becker, I; Zhou, JG; Hartmann, A; Fietkau, R; Iro, H; Döllinger, M; Gostian, AO; Kist, AM
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trial.
Neoplasia. 2024; 49:100953
Doi: 10.1016/j.neo.2023.100953
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB; Boda-Heggemann, J; Bürgy, D; Corradini, S; Dieckmann, UK; Gawish, A; Gerum, S; Gkika, E; Grohmann, M; Hörner-Rieber, J; Kirste, S; Klement, RJ; Moustakis, C; Nestle, U; Niyazi, M; Rühle, A; Lang, ST; Winkler, P; Zurl, B; Wittig-Sauerwein, A; Blanck, O
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery.
Strahlenther Onkol. 2024;
Doi: 10.1007/s00066-024-02254-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Seufferlein, T; Mayerle, J; Boeck, S; Brunner, T; Ettrich, TJ; Grenacher, L; Gress, TM; Hackert, T; Heinemann, V; Kestler, A; Sinn, M; Tannapfel, A; Wedding, U; Uhl, W
S3 Guideline on Exocrine Pancreatic Carcinoma - Version 3.1AWMF Registry Number: 032-010OL-Guideline (Long Version)
Z GASTROENTEROL. 2024; 62(10): e874-e995.
Doi: 10.1055/a-2338-3533
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, TB; Boda-Heggemann, J; Buergy, D; Corradini, S; Dieckmann, UK; Gerum, S; Gkika, E; Hoerner-Rieber, J; Kirste, S; Klement, R; Moustakis, C; Niyazi, M; Ruehle, A; Tanadini-Lang, S; Winkler, P; Zurl, B; Blanck, O
General and Organ Specific Consensus Recommendations for Stereotactic Body Radiotherapy Dose Prescription according to ICRU Report 91 from Working Groups on Stereotactic Radiotherapy
INT J RADIAT ONCOL. 2024; 120(2):S219-S220.-66th ASTRO International Conference; SEP 29-OCT 2, 2024; Washington, USA.
[Oral Communication]
Web of Science
** Brunner, TB; Lordick, F; Schmoor, C; Schmidberger, H; Kirste, S; Rieken, S; Petersen, C; Nicolay, NH; Fokas, E; Dunst, J; Rades, D; Eble, MJ; Krause, M; Roedel, C; Medenwald, D; Niehoff, P; Wittig-Sauerwein, A; Baues, C; Grosu, A; Hoeppner, J
Neoadjuvant Chemoradiation (CROSS) vs. Perioperative Chemotherapy (FLOT) in Esophageal Adenocarcinoma (EAC): ESOPEC - a Randomised Controlled Prospective Multicentre Phase Ill Trial
INT J RADIAT ONCOL. 2024; 120(2): S6-S6.
[Poster]
Web of Science
** Hoeppner, J; Brunner, T; Lordick, F; Schmoor, C; Kulemann, B; Neumann, UP; Folprecht, G; Keck, T; Benedix, F; Schmeding, M; Reitsamer, E; Bruns, CJ; Lock, JF; Reichert, B; Ghadimi, M; Wille, K; Gockel, I; Izbicki, JR; Utzolino, S; Grimminger, PP
Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).
J CLIN ONCOL. 2024; 42(17_SUPPL): LBA1
Doi: 10.1200/JCO.2024.42.17_suppl.LBA1
Web of Science
FullText
FullText_MUG
** Radicioni, G; Spohn, SKB; Eichhorst, A; R hle, A; Hartong, N; Popp, I; Adebahr, S; Brunner, TB; Grosu, AL; Gkika, E
Local control and toxicity after upper abdominal SBRT with Simultaneous Integrated Protection (SIP)
RADIOTHER ONCOL. 2024; 194: S2249-S2250.
[Poster]
Web of Science
** Seiss, L; Locsei, Z; Winkler, P; Stranzl-Lawatsch, H; Brunner, TB
Radiation Oncology Hands-on Undergraduate Teaching: Digital Cross Sectional Anatomy and Tumor Pathology in CT, MRI and PET
INT J RADIAT ONCOL. 2024; 120(2):E677-E677.-66th ASTRO International Conference; SEP 29-OCT 2, 2024; Washington, USA.
[Poster]
Web of Science
2023
Originalarbeit (Zeitschrift)
** Ademaj, A; Veltsista, PD; Marder, D; Hälg, RA; Puric, E; Brunner, TB; Crezee, H; Gabrys, D; Franckena, M; Gani, C; Horsman, MR; Krempien, R; Lindner, LH; Maluta, S; Notter, M; Petzold, G; Abdel-Rahman, S; Richetti, A; Thomsen, AR; Tsoutsou, P; Fietkau, R; Ott, OJ; Ghadjar, P; Riesterer, O
A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers.
Strahlenther Onkol. 2023; 199(5): 436-444.
Doi: 10.1007/s00066-022-01980-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bitzer, M; Groß, S; Albert, J; Boda-Heggemann, J; Brunner, T; Caspari, R; De, Toni, E; Dombrowski, F; Evert, M; Geier, A; Gkika, E; Götz, M; Helmberger, T; Hoffmann, RT; Huppert, P; Kautz, A; Krug, D; Fougère, C; Lang, H; Lenz, P; Lüdde, T; Mahnken, A; Nadalin, S; Nguyen, HHP; Ockenga, J; Oldhafer, K; Paprottka, P; Pereira, P; Persigehl, T; Plentz, R; Pohl, J; Recken, H; Reimer, P; Riemer, J; Ritterbusch, U; Roeb, E; Rüssel, J; Schellhaas, B; Schirmacher, P; Schlitt, HJ; Schmid, I; Schuler, A; Seehofer, D; Sinn, M; Stengel, A; Stoll, C; Tannapfel, A; Taubert, A; Tholen, R; Trojan, J; van, Thiel, I; Vogel, A; Vogl, T; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wildner, D; Wörns, MA; Galle, P; Malek, N
S3 guideline diagnostics and therapy of biliary carcinoma.
Z Gastroenterol. 2023; 61(4):420-440
Doi: 10.1055/a-2026-1277
Web of Science
PubMed
FullText
FullText_MUG
** Buchner, JA; Kofler, F; Etzel, L; Mayinger, M; Christ, SM; Brunner, TB; Wittig, A; Menze, B; Zimmer, C; Meyer, B; Guckenberger, M; Andratschke, N; El, Shafie, RA; Debus, J; Rogers, S; Riesterer, O; Schulze, K; Feldmann, HJ; Blanck, O; Zamboglou, C; Ferentinos, K; Wolff, R; Eitz, KA; Combs, SE; Bernhardt, D; Wiestler, B; Peeken, JC
Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter study.
Radiother Oncol. 2023; 178: 109425
Doi: 10.1016/j.radonc.2022.11.014
Web of Science
PubMed
FullText
FullText_MUG
** Buchner, JA; Peeken, JC; Etzel, L; Ezhov, I; Mayinger, M; Christ, SM; Brunner, TB; Wittig, A; Menze, BH; Zimmer, C; Meyer, B; Guckenberger, M; Andratschke, N; El, Shafie, RA; Debus, J; Rogers, S; Riesterer, O; Schulze, K; Feldmann, HJ; Blanck, O; Zamboglou, C; Ferentinos, K; Bilger, A; Grosu, AL; Wolff, R; Kirschke, JS; Eitz, KA; Combs, SE; Bernhardt, D; Rueckert, D; Piraud, M; Wiestler, B; Kofler, F
Identifying core MRI sequences for reliable automatic brain metastasis segmentation.
Radiother Oncol. 2023; 188: 109901
Doi: 10.1016/j.radonc.2023.109901
Web of Science
PubMed
FullText
FullText_MUG
** Gawish, A; Abdullayev, N; El-Arayedh, S; Röllich, B; Ochel, HJ; Brunner, TB
Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer.
Clin Transl Oncol. 2023; 25(4):987-994
Doi: 10.1007/s12094-022-03002-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gawish, A; Walke, M; Röllich, B; Ochel, HJ; Brunner, TB
Vestibular Schwannoma Hypofractionated Stereotactic Radiation Therapy in Five Fractions.
Clin Oncol (R Coll Radiol). 2023; 35(1):e40-e47
Doi: 10.1016/j.clon.2022.10.014
Web of Science
PubMed
FullText
FullText_MUG
** Gawish, A; Walke, M; Röllich, B; Ochel, HJ; Brunner, TB
Nodal and osseous oligometastatic prostate cancer: a cohort including the introduction of PSMA-PET/CT-guided stereotactic and hypofractionated radiotherapy with elective nodal therapy.
J Cancer Res Clin Oncol. 2023; 149(7):3937-3949
Doi: 10.1007/s00432-022-04229-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Kostyszyn, D; Fechter, T; Moustakis, C; Ernst, F; Boda-Heggemann, J; Sarria, G; Dieckmann, K; Dobiasch, S; Duma, MN; Eberle, F; Kroeger, K; Häussler, B; Izaguirre, V; Jazmati, D; Lautenschläger, S; Lohaus, F; Mantel, F; Menzel, J; Pachmann, S; Pavic, M; Radlanski, K; Riesterer, O; Gerum, S; Röder, F; Willner, J; Barczyk, S; Imhoff, D; Blanck, O; Wittig, A; Guckenberger, M; Grosu, AL; Brunner, TB
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities.
Strahlenther Onkol. 2023; 199(11):973-981
Doi: 10.1007/s00066-023-02085-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ott, D; Gawish, A; Lux, A; Heinze, C; Brunner, TB; Hass, P
Can alternative liver function scores facilitate the establishment of an indication for radioablative therapy in patients with hepatocellular carcinoma?
J Cancer Res Clin Oncol. 2023; 149(8):4817-4824
Doi: 10.1007/s00432-022-04411-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Paal, K; Brunner, T
[Not Available].
STRAHLENTHER ONKOL. 2023; 199(6): 607-610.
Doi: 10.1007/s00066-023-02087-5
Web of Science
PubMed
FullText
FullText_MUG
** Paal, K; Stranz, B; Thurner, EM; Langsenlehner, U; Renner, W; Brunner, TB; Langsenlehner, T
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients.
Strahlenther Onkol. 2023;
Doi: 10.1007/s00066-023-02132-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Partl, R; Paal, K; Stranz, B; Hassler, E; Magyar, M; Brunner, TB; Langsenlehner, T
The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer.
Diagnostics (Basel). 2023; 13(4):
Doi: 10.3390/diagnostics13040679
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Gawish, A; Abdulayev, N; El-Arayed, S; Röllich, B; Ochel, HJ; Brunner, TB
A single-center experience with linear accelerator-based stereotactic radiotherapy for meningiomas: hypofractionation and radiosurgery.
J Cancer Res Clin Oncol. 2023; 149(1):103-109
Doi: 10.1007/s00432-022-04450-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Korrektur
** Gawish, A; Abdullayev, N; El-Arayedh, S; Röllich, B; Ochel, HJ; Brunner, TB
Correction to: Metabolic response after 68 Ga‑PSMA‑PET/CT‑directed IGRT/SBRT for oligometastases prostate cancer.
Clin Transl Oncol. 2023; 25(4):1133
Doi: 10.1007/s12094-023-03104-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, T; Langsenlehner, T; Stranzl-Lawatsch, H; Winkler, P
Rise of irradiated patients with prostate cancer and no other tumours during the corona pandemy
RADIOTHER ONCOL. 2023; 182: S876-S877.-Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO); MAY 12-16, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
** Buchner, JA; Kofler, F; Mayinger, MC; Brunner, TB; Wittig, A; Menze, B; Zimmer, C; Meyer, B; Guckenberger, M; Andratschke, N; ElShafie, R; Rogers, S; Schulze, K; Blanck, O; Zamboglou, C; Grosu, A; Combs, SE; Bernhardt, D; Wiestler, B; Peeken, JC
What MRI Sequences are Necessary for Automated Neural Network-Based Metastasis Segmentation An Ablation Study
INT J RADIAT ONCOL. 2023; 117(2): E704-E705.
[Poster]
Web of Science
PubMed
** Kostyszyn, D; Sachpazidis, I; Thomann, B; Gawron, M; Radicioni, G; Brunner, T; Grosu, AL; Gkika, E; Baltas, D
Prescription-free, radiobiology-based inverse radiation planning
STRAHLENTHER ONKOL. 2023; 199: S46-S46.
[Poster]
Web of Science
** Locsei, Z; Nagy, B; Brunner, T; Mangel, L
Effect of radiotherapy in deep inspiration in patients with left breast cancer: Does the size of the target area affect the dose for the most crucial organs at risk?
ANN ONCOL. 2023; 34: S315-S315.
Doi: 10.1016/j.annonc.2023.09.526
[Poster]
Web of Science
FullText
FullText_MUG
** Paal, K; Stranz, B; Hassler, E; Magyar, M; Brunner, TB; Langsenlehner, T; Partl, R
Prognostic Significance of Platelet-Leukocyte Ratio in Patients undergoing neoadjuvant radiochemotherapy for Rectal Cancer
STRAHLENTHER ONKOL. Abstracts. 2023; 199(S1):S74-S74.-29th Annual Congress of the DEGRO; JUN 22-24, 2023; Kassel, GERMANY.
[Poster]
Web of Science
** Paal, K; Stranz, B; Thurner, EM; Brunner, TB; Langsenlehner, T;
Association between age-associated Biomarkers and radiogenic Acute Toxicity in Prostate Cancer Patients
STRAHLENTHER ONKOL. Abstracts. 2023; 199(S1):S12-S12.-29th Annual Congress of the DEGRO; JUN 22-24, 2023; Kassel, GERMANY.
[Oral Communication]
Web of Science
** Santic, J; Paal, K; Stranzl-Lawatsch, H; Langsenlehner, T; Winkler, P; Brunner, T
COVID-19 and its Consequences: Isolated Increase in Patients treated with Radiation Oncology only for Prostate Cancer during the Pandemic
STRAHLENTHER ONKOL. Abstracts. 2023; 199(S1):S149-S149.-29th Annual Congress of the DEGRO; JUN 22-24, 2023; Kassel, GERMANY.
[Poster]
Web of Science
** Tamaskovics, BF; Hecht, M; Schubert, P; Kallies, A; Illmer, T; Radke, J; Koelbl, O; Steger, F; Brunner, TB; Rödel, C; Fleischmann, M; Reinacher-Schick, A; Wingender, LF; Melchior, P; Klautke, G; Hintzen, U; Gaipl, US; Haussmann, J; Budach, W; Fietkau, R
Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial
ANN ONCOL. 2023; 34: S593-S593.
Doi: 10.1016/j.annonc.2023.09.2088
[Poster]
Web of Science
FullText
FullText_MUG
Guideline/Konsensuspapier
** Bitzer, M; Groß, S; Albert, J; Boda-Heggemann, J; Brunner, T; Caspari, R; De, Toni, E; Dombrowski, F; Evert, M; Geier, A; Gkika, E; Götz, M; Helmberger, T; Hoffmann, RT; Huppert, P; Kautz, A; Krug, D; Fougère, C; Lang, H; Lenz, P; Lüdde, T; Mahnken, A; Nadalin, S; Nguyen, HHP; Ockenga, J; Oldhafer, K; Paprottka, P; Pereira, P; Persigehl, T; Plentz, R; Pohl, J; Recken, H; Reimer, P; Riemer, J; Ritterbusch, U; Roeb, E; Rüssel, J; Schellhaas, B; Schirmacher, P; Schlitt, HJ; Schmid, I; Schuler, A; Seehofer, D; Sinn, M; Stengel, A; Stoll, C; Tannapfel, A; Taubert, A; Tholen, R; Trojan, J; van, Thiel, I; Vogel, A; Vogl, T; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wildner, D; Wörns, MA; Galle, P; Malek, N
S3 guideline diagnostics and therapy of biliary carcinoma - long version.
Z Gastroenterol. 2023; 61(4):e92-e156
Doi: 10.1055/a-2026-1240
Web of Science
PubMed
FullText
FullText_MUG
2022
Originalarbeit (Zeitschrift)
** Beck, M; Hartwich, J; Eckstein, M; Schmidt, D; Gostian, AO; Müller, S; Rutzner, S; Gaipl, US; von, der, Grün, J; Illmer, T; Hautmann, MG; Klautke, G; Döscher, J; Brunner, T; Tamaskovics, B; Hartmann, A; Iro, H; Kuwert, T; Fietkau, R; Hecht, M; Semrau, S
F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial.
Ann Nucl Med. 2022; 36(7): 623-633.
Doi: 10.1007/s12149-022-01744-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bitzer, M; Voesch, S; Albert, J; Bartenstein, P; Bechstein, W; Blödt, S; Brunner, T; Dombrowski, F; Evert, M; Follmann, M; La, Fougère, C; Freudenberger, P; Geier, A; Gkika, E; Götz, M; Hammes, E; Helmberger, T; Hoffmann, RT; Hofmann, WP; Huppert, P; Kautz, A; Knötgen, G; Körber, J; Krug, D; Lammert, F; Lang, H; Langer, T; Lenz, P; Mahnken, A; Meining, A; Micke, O; Nadalin, S; Nguyen, HP; Ockenga, J; Oldhafer, K; Paprottka, P; Paradies, K; Pereira, P; Persigehl, T; Plauth, M; Plentz, R; Pohl, J; Riemer, J; Reimer, P; Ringwald, J; Ritterbusch, U; Roeb, E; Schellhaas, B; Schirmacher, P; Schmid, I; Schuler, A; von, Schweinitz, D; Seehofer, D; Sinn, M; Stein, A; Stengel, A; Steubesand, N; Stoll, C; Tannapfel, A; Taubert, A; Trojan, J; van, Thiel, I; Tholen, R; Vogel, A; Vogl, T; Vorwerk, H; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wildner, D; Wittekind, C; Wörns, MA; Galle, P; Malek, N
[Not Available].
Z Gastroenterol. 2022; 60(2): 219-238.
Doi: 10.1055/a-1589-7638
Web of Science
PubMed
FullText
FullText_MUG
** Bitzer, M; Voesch, S; Albert, J; Bartenstein, P; Bechstein, W; Blödt, S; Brunner, T; Dombrowski, F; Evert, M; Follmann, M; La, Fougère, C; Freudenberger, P; Geier, A; Gkika, E; Götz, M; Hammes, E; Helmberger, T; Hoffmann, RT; Hofmann, WP; Huppert, P; Kautz, A; Knötgen, G; Körber, J; Krug, D; Lammert, F; Lang, H; Langer, T; Lenz, P; Mahnken, A; Meining, A; Micke, O; Nadalin, S; Nguyen, HP; Ockenga, J; Oldhafer, K; Paprottka, P; Paradies, K; Pereira, P; Persigehl, T; Plauth, M; Plentz, R; Pohl, J; Riemer, J; Reimer, P; Ringwald, J; Ritterbusch, U; Roeb, E; Schellhaas, B; Schirmacher, P; Schmid, I; Schuler, A; von, Schweinitz, D; Seehofer, D; Sinn, M; Stein, A; Stengel, A; Steubesand, N; Stoll, C; Tannapfel, A; Taubert, A; Trojan, J; van, Thiel, I; Tholen, R; Vogel, A; Vogl, T; Vorwerk, H; Wacker, F; Waidmann, O; Wedemeyer, H; Wege, H; Wildner, D; Wittekind, C; Wörns, MA; Galle, P; Malek, N
[Not Available].
Z Gastroenterol. 2022; 60(2): e186-e227.
Doi: 10.1055/a-1589-7854
Web of Science
PubMed
FullText
FullText_MUG
** Buergy, D; Würschmidt, F; Gkika, E; Hörner-Rieber, J; Knippen, S; Gerum, S; Balermpas, P; Henkenberens, C; Voglhuber, T; Kornhuber, C; Barczyk, S; Röper, B; Rashid, A; Blanck, O; Wittig, A; Herold, HU; Brunner, TB; Sweeney, RA; Kahl, KH; Ciernik, IF; Ottinger, A; Izaguirre, V; Putz, F; König, L; Hoffmann, M; Combs, SE; Guckenberger, M; Boda-Heggemann, J
Stereotactic body radiotherapy of adrenal metastases-A dose-finding study.
Int J Cancer. 2022; 151(3): 412-421.
Doi: 10.1002/ijc.34017
Web of Science
PubMed
FullText
FullText_MUG
** Fokas, E; Schlenska-Lange, A; Polat, B; Klautke, G; Grabenbauer, GG; Fietkau, R; Kuhnt, T; Staib, L; Brunner, T; Grosu, AL; Kirste, S; Jacobasch, L; Allgäuer, M; Flentje, M; Germer, CT; Grützmann, R; Hildebrandt, G; Schwarzbach, M; Bechstein, WO; Sülberg, H; Friede, T; Gaedcke, J; Ghadimi, M; Hofheinz, RD; Rödel, C, , German, Rectal, Cancer, Study, Group
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.
JAMA Oncol. 2022; 8(1): e215445
Doi: 10.1001/jamaoncol.2021.5445
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gawish, A; Röllich, B; Ochel, HJ; Brunner, TB
Linac-based stereotactic radiosurgery for brain arteriovenous malformations.
Radiat Oncol. 2022; 17(1):161
Doi: 10.1186/s13014-022-02130-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Grosu, AL; Macarulla, Mercade, T; Cubillo, Gracián, A; Brunner, TB; Schultheiß, M; Pazgan-Simon, M; Seufferlein, T; Touchefeu, Y
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study.
Cancers (Basel). 2022; 14(6):
Doi: 10.3390/cancers14061568
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hecht, M; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Klautke, G; Laban, S; Hautmann, MG; Brunner, TB; Tamaskovics, B; Hinke, A; Zhou, JG; Frey, B; Donaubauer, AJ; Becker, I; Semrau, S; Hartmann, A; Balermpas, P; Budach, W; Gaipl, US; Iro, H; Gostian, AO; Fietkau, R
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer.
J Immunother Cancer. 2022; 10(1):
Doi: 10.1136/jitc-2021-003747
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Medenwald, D; Brunner, T; Christiansen, H; Kisser, U; Mansoorian, S; Vordermark, D; Prokosch, HU; Seuchter, SA; Kapsner, LA, , our, MII, research, group
Shift of radiotherapy use during the first wave of the COVID-19 pandemic? An analysis of German inpatient data.
Strahlenther Onkol. 2022; 198(4): 334-345.
Doi: 10.1007/s00066-021-01883-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Seufferlein, T; Mayerle, J; Böck, S; Brunner, T; Ettrich, TJ; Grenacher, L; Gress, TM; Hackert, T; Heinemann, V; Kestler, A; Sinn, M; Tannapfel, A; Wedding, U; Uhl, W
[Not Available].
Z Gastroenterol. 2022; 60(11):e812-e909
Doi: 10.1055/a-1856-7346
Web of Science
PubMed
FullText
FullText_MUG
** Seufferlein, T; Mayerle, J; Böck, S; Brunner, T; Ettrich, TJ; Grenacher, L; Gress, TM; Hackert, T; Heinemann, V; Kestler, A; Sinn, M; Tannapfel, A; Wedding, U; Uhl, W
[Not Available].
Z Gastroenterol. 2022; 60(6):991-1037
Doi: 10.1055/a-1771-6811
Web of Science
PubMed
FullText
FullText_MUG
** Shi, W; Li, C; Wartmann, T; Kahlert, C; Du, R; Perrakis, A; Brunner, T; Croner, RS; Kahlert, UD
Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents.
J Pers Med. 2022; 12(3):
Doi: 10.3390/jpm12030478
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB; Wördehoff, H; Gawish, A; Busch, U
125 years of head and neck radiotherapy: could organ-sparing radiotherapy of larynx cancer have prevented World War I?
Strahlenther Onkol. 2022; 198(4): 325-333.
Doi: 10.1007/s00066-022-01902-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kommentar
** Brunner, T
[A story of hypofractionation and the "Table on the Wall"].
Strahlenther Onkol. 2022; 198(8):759-760
Doi: 10.1007/s00066-022-01947-w
Web of Science
PubMed
FullText
FullText_MUG
** Seiß, L; Brunner, T
[Side effect profile of early immunotherapy after radiotherapy: a pooled analysis of studies in the US Food and Drug Administration database].
Strahlenther Onkol. 2022; 198(11):1049-1051
Doi: 10.1007/s00066-022-01995-2
Web of Science
PubMed
FullText
FullText_MUG
2021
Originalarbeit (Zeitschrift)
** Brunner, TB; Bettinger, D; Schultheiss, M; Maruschke, L; Sturm, L; Bartl, N; Koundurdjieva, I; Kirste, S; Neeff, HP; Goetz, C; Nicolay, NH; Ihorst, G; Bamberg, F; Thimme, R; Grosu, AL; Gkika, E
Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study).
Front Oncol. 2021; 11: 653141
Doi: 10.3389/fonc.2021.653141
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Haustermans, K; Huguet, F; Morganti, AG; Mukherjee, S; Belka, C; Krempien, R; Hawkins, MA; Valentini, V; Roeder, F
ESTRO ACROP guidelines for target volume definition in pancreatic cancer.
Radiother Oncol. 2021; 154: 60-69.
Doi: 10.1016/j.radonc.2020.07.052
Web of Science
PubMed
FullText
FullText_MUG
** Buergy, D; Würschmidt, F; Gkika, E; Hörner-Rieber, J; Knippen, S; Gerum, S; Balermpas, P; Henkenberens, C; Voglhuber, T; Kornhuber, C; Barczyk, S; Röper, B; Rashid, A; Blanck, O; Wittig, A; Herold, HU; Brunner, TB; Klement, RJ; Kahl, KH; Ciernik, IF; Ottinger, A; Izaguirre, V; Putz, F; König, L; Hoffmann, M; Combs, SE; Guckenberger, M; Boda-Heggemann, J
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.
Int J Cancer. 2021; 149(2): 358-370.
Doi: 10.1002/ijc.33546
Web of Science
PubMed
FullText
FullText_MUG
** Mohamed, AA; Thomsen, A; Follo, M; Zamboglou, C; Bronsert, P; Mostafa, H; Amen, A; Mekawy, M; Grosu, AL; Brunner, TB
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
Strahlenther Onkol. 2021; 197(1): 27-38.
Doi: 10.1007/s00066-020-01666-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schneider, R; Gademann, G; Ochel, HJ; Neumann, K; Jandrig, B; Hass, P; Walke, M; Schostak, M; Brunner, T; Christoph, F
Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145.
Radiat Oncol. 2021; 16(1): 137
Doi: 10.1186/s13014-021-01859-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Semrau, S; Gostian, AO; Traxdorf, M; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Hautmann, M; Klautke, G; Laban, S; Brunner, T; Tamaskovics, B; Frey, B; Zhou, JG; Geppert, CI; Hartmann, A; Balermpas, P; Budach, W; Gaipl, U; Iro, H; Fietkau, R; Hecht, M
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.
Cancers (Basel). 2021; 13(8):
Doi: 10.3390/cancers13081959
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Valentini, V; Cellini, F; Riddell, A; Brunner, TB; Roeder, F; Giuliante, F; Alfieri, S; Manfredi, R; Ardito, F; Fiorillo, C; Porziella, V; Morganti, AG; Haustermans, K; Margaritora, S; De, Bari, B; Matzinger, O; Gkika, E; Belka, C; Allum, W; Verheij, M
ESTRO ACROP guidelines for the delineation of lymph nodal areas in upper gastrointestinal malignancies.
Radiother Oncol. 2021; 164: 92-97.
Doi: 10.1016/j.radonc.2021.08.026
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Birrer, DL; Golcher, H; Casadei, R; Haile, SR; Fritsch, R; Hussung, S; Brunner, TB; Fietkau, R; Meyer, T; Grützmann, R; Merkel, S; Ricci, C; Ingaldi, C; Di, Marco, M; Guido, A; Serra, C; Minni, F; Pestalozzi, B; Petrowsky, H; DeOliveira, M; Bechstein, WO; Bruns, CJ; Oberkofler, CE; Puhan, M; Lesurtel, M; Heinrich, S; Clavien, PA
Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials.
Ann Surg. 2021; 274(5): 713-720.
Doi: 10.1097/SLA.0000000000005126
Web of Science
PubMed
FullText
FullText_MUG
** Partelli, S; Sclafani, F; Barbu, ST; Beishon, M; Bonomo, P; Braz, G; de, Braud, F; Brunner, T; Cavestro, GM; Crul, M; Trill, MD; Ferollà, P; Herrmann, K; Karamitopoulou, E; Neuzillet, C; Orsi, F; Seppänen, H; Torchio, M; Valenti, D; Zamboni, G; Zins, M; Costa, A; Poortmans, P
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer.
Cancer Treat Rev. 2021; 99: 102208
Doi: 10.1016/j.ctrv.2021.102208
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Hass, P; Brunner, TB; Gawish, A; Ott, D
ALBI & IBI score could help in deciding for or against a radioablative therapy in patients with HCC
RADIOTHER ONCOL. 2021; 161: S1015-S1016.
Web of Science
** Hass, P; Walke, M; Gawish, A; Brunner, TB
Is local ablative radiotherapy for liver malignancies an alternative to surgical resection?
RADIOTHER ONCOL. 2021; 161: S1202-S1203.
Web of Science
2020
Originalarbeit (Zeitschrift)
** Brunner, TB; Croner, RS
[Neoadjuvant radiotherapy improves overall survival and disease-free interval in resectable hepatocellular carcinoma with portal vein tumor thrombosis].
Strahlenther Onkol. 2020; 196(2):194-196
Doi: 10.1007/s00066-019-01570-2
Web of Science
PubMed
FullText
FullText_MUG
** Fischbach, F; Hass, P; Schindele, D; Genseke, P; Geisendorf, L; Stehning, C; Schostak, M; Brunner, T; Pech, M; Fischbach, K
MRI targeted single fraction HDR Brachytherapy for localized Prostate Carcinoma: a feasibility study of focal radiation therapy (ProFocAL).
Eur Radiol. 2020; 30(4):2072-2081
Doi: 10.1007/s00330-019-06505-0
Web of Science
PubMed
FullText
FullText_MUG
** Hecht, M; Gostian, AO; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Hautmann, MG; Klautke, G; Laban, S; Brunner, T; Hinke, A; Becker, I; Frey, B; Semrau, S; Geppert, CI; Hartmann, A; Balermpas, P; Budach, W; Gaipl, US; Iro, H; Fietkau, R
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.
J Immunother Cancer. 2020; 8(2):
Doi: 10.1136/jitc-2020-001378
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heinze, C; Omari, J; Damm, R; Hass, P; Brunner, T; Surov, A; Seidesticker, R; Seidensticker, M; Ricke, J; Powerski, M; Pech, M
Interstitial Brachytherapy for Limited (<4 cm) and Large (≥4 cm) Hepatic Metastases from Rare and Less Common Cancers.
Anticancer Res. 2020; 40(8): 4281-4289.
Doi: 10.21873/anticanres.14430
Web of Science
PubMed
FullText
FullText_MUG
** Schaefer, C; Zamboglou, C; Volegova-Neher, N; Martini, C; Nicolay, NH; Schmidt-Hegemann, NS; Rogowski, P; Li, M; Belka, C; Müller, AC; Grosu, AL; Brunner, T
Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer - a prospective pilot study.
Radiat Oncol. 2020; 15(1):27
Doi: 10.1186/s13014-020-1474-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Afifi, ANAM; Powerski, M; Jechorek, D; Brunner, TB; Weigt, J; Venerito, M
Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options.
Best Pract Res Clin Gastroenterol. 2020; 48-49: 101711
Doi: 10.1016/j.bpg.2020.101711
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Hawkins, MA; Grosu, AL; Brunner, TB
The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer.
Front Oncol. 2020; 10: 604387
Doi: 10.3389/fonc.2020.604387
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prades, J; Arnold, D; Brunner, T; Cardone, A; Carrato, A; Coll-Ortega, C; De, Luze, S; Garel, P; Goossens, ME; Grilli, R; Harris, M; Louagie, M; Malats, N; Minicozzi, P; Partelli, S; Pastorekova, S; Petrulionis, M; Price, R; Sclafani, F; Smolkova, B; Borras, JM
Bratislava Statement: consensus recommendations for improving pancreatic cancer care.
ESMO Open. 2020; 5(6): e001051
Doi: 10.1136/esmoopen-2020-001051
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, TB; Bettinger, D; Schultheiss, M; Maruschke, L; Bartl, N; Kirste, S; Bamberg, F; Thimme, R; Grosu, A; Gkika, E
Stereotactic Body Radiotherapy vs Transarterial Chemoembolization In Locally Advanced Hepatocellular Carcinoma (HERACLES: Hepatocellular Carcinoma Stereotactic Radiotherapy Clinical Efficacy Study)
INT J RADIAT ONCOL. 2020; 108(3): E574-E574.
Web of Science
** Gkika, E; Moustakis, C; Fechter, T; Ernst, F; Saria-Vargas, G; Dieckmann, K; Dobiasch, S; Duma, MN; Eberle, F; Gerum, S; Haussler, B; Izaguirre, V; Jazmati, D; Lautenschlager, S; Lohaus, F; Mantel, F; Menzel, J; Pachmann, S; Pavic, M; Radlanski, K; Riesterer, O; Roder, F; Trog, D; Willner, J; Blanck, O; Brunner, TB
Inter-observer Variability in the Target Volume Definition for stereotactic Radiation Therapy of Pancreatic Cancer. A Study by DEGRO AG Stereotaxy
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S98-S99.
Web of Science
** Gomez, J; Castano, F; Castilla, L; Corral, S; Acosta, J; Araguas, P; Torres, L; Arquez, M; Arguis, M; Gomez, D; Lopez, Y; Murcia, M; Gomez, E; Aparicio, C; Atanassoff, A; Blanco, J; Tomas, ER; Brunner, TB; Pazos, M; Arenas, M
Reirradiation in Breast Cancer: Clinical Outcome and Dosimetric Aspects of a Retrospective Study
INT J RADIAT ONCOL. 2020; 108(3): E68-E68.
Web of Science
** Grosser, OS; Walke, M; Abdullayev, N; Andrae, K; Wordehoff, H; Kreissl, MC; Brunner, TB
Assessment of the Risk of Liver Toxicity of liver SBRT after Selective internal Radiotherapy (SIRT)
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S102-S102.
Web of Science
** Hass, P; Walke, M; Wordehoff, H; Brunner, TB; Mohnike, K
Is a local ablative Radiotherapy, e.g. in Form of an interstitial HDR-Brachytherapy of primary or secondary Liver Malignancies an Alternative to Surgical Resection?
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S100-S100.
Web of Science
** Ochel, HJ; Gabriel, C; Waldleben, AM; Wolleschak, D; Gademann, G; Fischer, T; Walke, M; Brunner, TB; Heinicke, T
Allogeneic Stem Cell Transplantation after Whole Body Irradiation with helical Tomotherapy
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S56-S56.
Web of Science
** Ott, D; Brunner, TB; Hass, P
Can alternative Liver Function Scores facilitate the Indication for radioablative Therapy in Patients with hepatocellular Carcinoma?
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S88-S89.
Web of Science
Kommentar
** Boda-Heggemann, J; Hofheinz, R; Gkika, E; Brunner, T; Krug, D
Beyond the scalpel - mortality after liver surgery in patients with liver metastases - time to rethink the indications.
Br J Surg. 2020; 107(1):149
Doi: 10.1002/bjs.11412
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB
[Pravastatin is capable to reduce radiation induced fibrosis after head-and-neck treatment].
Strahlenther Onkol. 2020; 196(1):104-106
Doi: 10.1007/s00066-019-01544-4
Web of Science
PubMed
FullText
FullText_MUG
** Krug, D; Hofheinz, R; Gkika, E; Brunner, T; Boda-Heggemann, J
[Unexpectedly high mortality after surgical liver interventions in Germany].
Strahlenther Onkol. 2020; 196(1):98-100
Doi: 10.1007/s00066-019-01547-1
Web of Science
PubMed
FullText
FullText_MUG
2019
Originalarbeit (Zeitschrift)
** Bettinger, D; Pinato, DJ; Schultheiss, M; Sharma, R; Rimassa, L; Pressiani, T; Burlone, ME; Pirisi, M; Kudo, M; Park, JW; Buettner, N; Neumann-Haefelin, C; Boettler, T; Abbasi-Senger, N; Alheit, H; Baus, W; Blanck, O; Gerum, S; Guckenberger, M; Habermehl, D; Ostheimer, C; Riesterer, O; Tamihardja, J; Grosu, AL; Thimme, R; Brunner, TB; Gkika, E
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis.
Liver Cancer. 2019; 8(4):281-294
Doi: 10.1159/000490260
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Blanck, O; Lewitzki, V; Abbasi-Senger, N; Momm, F; Riesterer, O; Duma, MN; Wachter, S; Baus, W; Gerum, S; Guckenberger, M; Gkika, E
Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Radiother Oncol. 2019; 132:42-47
Doi: 10.1016/j.radonc.2018.11.015
Web of Science
PubMed
FullText
FullText_MUG
** Chuong, MD; Kaiser, A; Khan, F; Parikh, P; Ben-Josef, E; Crane, C; Brunner, T; Okumura, T; Schreuder, N; Bentzen, SM; Gutierrez, A; Mendez, Romero, A; Yoon, SM; Sharma, N; Kim, TH; Kishi, K; Moeslein, F; Hoffe, S; Schefter, T; Hanish, S; Scorsetti, M; Apisarnthanarax, S
Consensus Report From the Miami Liver Proton Therapy Conference.
Front Oncol. 2019; 9:457
Doi: 10.3389/fonc.2019.00457
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fokas, E; Allgäuer, M; Polat, B; Klautke, G; Grabenbauer, GG; Fietkau, R; Kuhnt, T; Staib, L; Brunner, T; Grosu, AL; Schmiegel, W; Jacobasch, L; Weitz, J; Folprecht, G; Schlenska-Lange, A; Flentje, M; Germer, CT; Grützmann, R; Schwarzbach, M; Paolucci, V; Bechstein, WO; Friede, T; Ghadimi, M; Hofheinz, RD; Rödel, C, , German, Rectal, Cancer, Study, Group
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.
J Clin Oncol. 2019; 37(34): 3212-3222.
Doi: 10.1200/JCO.19.00308
PubMed
FullText
FullText_MUG
** Gkika, E; Strouthos, I; Kirste, S; Adebahr, S; Schultheiss, M; Bettinger, D; Fritsch, R; Brass, V; Maruschke, L; Neeff, HP; Lang, SA; Nestle, U; Grosu, AL; Brunner, TB
Repeated SBRT for in- and out-of-field recurrences in the liver.
Strahlenther Onkol. 2019; 195(3):246-253
Doi: 10.1007/s00066-018-1385-0
Web of Science
PubMed
FullText
FullText_MUG
** Hass, P; Mohnike, K; Kropf, S; Brunner, TB; Walke, M; Albers, D; Petersen, C; Damm, R; Walter, F; Ricke, J; Powerski, M; Corradini, S
Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies.
Brachytherapy. 2019; 18(6):823-828
Doi: 10.1016/j.brachy.2019.08.003
Web of Science
PubMed
FullText
FullText_MUG
** Hass, P; Steffen, IG; Powerski, M; Mohnike, K; Seidensticker, M; Meyer, F; Brunner, T; Damm, R; Willich, C; Walke, M; Karagiannis, E; Omari, J; Ricke, J
First report on extended distance between tumor lesion and adjacent organs at risk using interventionally applied balloon catheters: a simple procedure to optimize clinical target volume covering effective isodose in interstitial high-dose-rate brachytherapy of liver malignomas.
J Contemp Brachytherapy. 2019; 11(2):152-161
Doi: 10.5114/jcb.2019.84798
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klement, RJ; Abbasi-Senger, N; Adebahr, S; Alheid, H; Allgaeuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Eble, MJ; Ernst, I; Gerum, S; Habermehl, D; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, H; Klass, ND; Krempien, R; Lewitzki, V; Lohaus, F; Ostheimer, C; Papachristofilou, A; Petersen, C; Rieber, J; Schneider, T; Schrade, E; Semrau, R; Wachter, S; Wittig, A; Guckenberger, M; Andratschke, N
The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
BMC Cancer. 2019; 19(1):173
Doi: 10.1186/s12885-019-5362-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kroeze, SGC; Fritz, C; Basler, L; Gkika, E; Brunner, TB; Grosu, AL; Guckenberger, M
Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries.
Strahlenther Onkol. 2019; 195(3):199-206
Doi: 10.1007/s00066-018-01422-5
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Wilke, L; Andratschke, N; Blanck, O; Brunner, TB; Combs, SE; Grosu, AL; Moustakis, C; Schmitt, D; Baus, WW; Guckenberger, M
ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery.
Strahlenther Onkol. 2019; 195(3):193-198
Doi: 10.1007/s00066-018-1416-x
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Adebahr, S; Wagner, K; Brunner, TB; Gkika, E; Rischke, HC; Grosu, A; Vach, W; Nestle, U
Evaluation of High-Risk Imaging Features for Detection of Local Progression after Stereotactic Body Radiotherapy (SBRT) of Malignant Pulmonary Lesions in the prospective STRIPE -trial
INT J RADIAT ONCOL. 2019; 105(1): S145-S145.
Doi: 10.1016/j.ijrobp.2019.06.144
Web of Science
FullText
FullText_MUG
** Bartl, N; Adebahr, S; Kirste, S; Popp, I; Schafer, H; Grosu, A; Brunner, TB; Gkika, E
The role of FDG PET / CT in SBRT of primary tumors in the upper abdomen
RADIOTHER ONCOL. 2019; 133: S781-S782.
Web of Science
** Bartl, N; Adebahr, S; Kirste, S; Popp, I; Schafer, H; Grosu, A; Brunner, TBB; Gkika, E
The prognostic significance of neutrophil / lymphocyte ratio for SBRT of cholangiocellular carcinoma
RADIOTHER ONCOL. 2019; 133: S781-S781.
Web of Science
** Brunner, TB; Bettinger, D; Schultheiss, M; Maruschke, L; Bartl, N; Kirste, S; Bamberg, F; Ihorst, G; Thimme, R; Grosu, A; Gkika, E
The Role of Stereotactic Body Radiotherapy (SBRT) in Locally Advanced Hepatocellular Carcinoma Versus Transarterial Chemoembolization (TACE): A Prospective, Non-Randomized Observational Trial (HERACLES)
INT J RADIAT ONCOL. 2019; 105(1): E214-E214.
Doi: 10.1016/j.ijrobp.2019.06.2058
Web of Science
FullText
FullText_MUG
** Gkika, E; Bettinger, D; Schultheiss, M; Maruschke, L; Bartl, N; Kirste, S; Bamberg, F; Thimme, R; Grosu, AL; Brunner, TB
The Role of stereotactic Radiotherapy (SBRT) in locally advanced hepatocellular Carcinoma compared with transarterial Chemoembolization (TACE). A prospective, non-randomized Observational Study (Heracles Study)
STRAHLENTHER ONKOL. 2019; 195: S7-S7.
Web of Science
** Gkika, E; Nugues, L; Weis, C; Bartl, N; Kirste, S; Adebahr, S; Wiehle, R; Baltas, D; Brunner, TB; Grosu, AL
Central hepatobiliary Toxicity in hypofractionated and stereotactic Radiotherapy of the Liver. Do we need Constraints?
STRAHLENTHER ONKOL. 2019; 195: S70-S70.
Web of Science
** Gkika, E; Poujol, M; Bartl, N; Wiehle, R; Baltas, D; Kirste, S; Adebahr, S; Grosu, AL; Brunner, TB
Evaluation of gastrointestinal Dose Limits in stereotactic and hypofractionated Radiotherapy of the Abdomen. What is "safe"?
STRAHLENTHER ONKOL. 2019; 195: S38-S38.
Web of Science
** Grosu, A; Ckika, E; Brunner, T; Strouthos, J; Weinberg, U
Phase 2 HEPANOVA trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma
ANN ONCOL. 2019; 30:
Web of Science
** Hass, P; Brunner, TB; Walke, M; Albers, D; Gauer, T; Petersen, C; Walter, F; Ricke, J; Corradini, S
Local Radio Ablation in Liver Malignancies: Which Method is better? ESPRIT Study: A dosimetric Comparison of interstitial HDR Brachytherapy (iBT) and Body Stereotactic (SBRT)
STRAHLENTHER ONKOL. 2019; 195: S103-S103.
Web of Science
** Hass, P; Drews, R; Omari, J; Othmer, M; Pech, M; Powerski, M; Brunner, TB
CT-assisted local ablative interstitial HDR Brachytherapy of hepatic, pancreatic or LK Oligometastases in metastatic Gastric Adenocarcinoma as Second-line or Salvage Therapy
STRAHLENTHER ONKOL. 2019; 195: S101-S101.
Web of Science
** Hass, P; Meyer, F; Costa, SD; Liehr, U; Perrakis, A; Croner, RS; Brunner, TB
Locally advanced Cervical Carcinoma with extensive vaginal Fistula: Case Description of 2 individual trimodal Treatment Concepts
STRAHLENTHER ONKOL. 2019; 195: S101-S101.
Web of Science
** Hass, P; Walke, M; Willich, C; Braun-Dullaeus, RC; Dittrich, I; Brunner, TB
Personalized Radioimmunotherapy as a Re-treatment of extensive right ventricular Metastasis of NSCLC (non-small cell Lung Carcinoma)
STRAHLENTHER ONKOL. 2019; 195: S94-S95.
Web of Science
** Hofheinz, R; Fokas, E; Allgauer, M; Polat, B; Klautke, G; Grabenbauer, G; Fietkau, R; Kuhnt, T; Staib, L; Brunner, T; Grosu, A; Schmiegel, W; Jacobasch, L; Weitz, J; Folprecht, G; Germer, C; Grutzmann, R; Schwarzbach, M; Bechstein, W; Friede, T; Ghadimi, M; Rodel, C
Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12
ANN ONCOL. 2019; 30:
Web of Science
Kommentar
** Willich, C; Brunner, TB
[Adjuvant chemotherapy with cisplatin and gemcitabine after radiochemotherapy with curative intent does not improve relapse-free survival in nasopharyngeal cancer patients with persistently detectable EBV DNA].
Strahlenther Onkol. 2019; 195(1):90-91
Doi: 10.1007/s00066-018-1393-0
Web of Science
PubMed
FullText
FullText_MUG
2018
Originalarbeit (Zeitschrift)
** Andratschke, N; Alheid, H; Allgäuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Gerum, S; Guckenberger, M; Hildebrandt, G; Klement, RJ; Lewitzki, V; Ostheimer, C; Papachristofilou, A; Petersen, C; Schneider, T; Semrau, R; Wachter, S; Habermehl, D
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
BMC Cancer. 2018; 18(1):283
Doi: 10.1186/s12885-018-4191-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bettinger, D; Gkika, E; Schultheiss, M; Glaser, N; Lange, S; Maruschke, L; Buettner, N; Kirste, S; Nestle, U; Grosu, AL; Thimme, R; Brunner, TB
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.
BMC Cancer. 2018; 18(1):807
Doi: 10.1186/s12885-018-4696-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Bettinger, D; Krafft, L; Schultheiss, M; Neeff, HP; Maruschke, L; Schulenburg, M; Adebahr, S; Kirste, S; Nestle, U; Thimme, R; Grosu, AL; Brunner, TB
The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.
Strahlenther Onkol. 2018; 194(5):403-413
Doi: 10.1007/s00066-017-1256-0
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Oehlke, O; Bunea, H; Wiedenmann, N; Adebahr, S; Nestle, U; Zamboglou, C; Kirste, S; Fennell, J; Brunner, T; Gainey, M; Baltas, D; Langer, M; Urbach, H; Bock, M; Meyer, PT; Grosu, AL
Biological imaging for individualized therapy in radiation oncology: part II medical and clinical aspects.
Future Oncol. 2018; 14(8):751-769
Doi: 10.2217/fon-2017-0465
Web of Science
PubMed
FullText
FullText_MUG
** Wendler, JJ; Damm, R; Liehr, UB; Brunner, T; Pech, M; Schostak, M
[Small renal cell carcinoma-active surveillance and ablation].
Urologe A. 2018; 57(6):731-743
Doi: 10.1007/s00120-018-0677-4
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB; Walke, M; Hass, P
[Clinical target volume : Principles and limits].
Radiologe. 2018; 58(8):730-735
Doi: 10.1007/s00117-018-0414-4
Web of Science
PubMed
FullText
FullText_MUG
** Schaub, SK; Hartvigson, PE; Lock, MI; Høyer, M; Brunner, TB; Cardenes, HR; Dawson, LA; Kim, EY; Mayr, NA; Lo, SS; Apisarnthanarax, S
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.
Technol Cancer Res Treat. 2018; 17:1533033818790217
Doi: 10.1177/1533033818790217
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wendler, JJ; Liehr, BU; Damm, R; Powerski, M; Brunner, T; Schostak, M; Pech, M
Small renal carcinoma: the "when" and "how" of operation, active surveillance, and ablation.
Pol J Radiol. 2018; 83: e561-e568.
Doi: 10.5114/pjr.2018.81282
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Fallbericht
** Kirste, S; Kayser, G; Zipfel, A; Grosu, AL; Brunner, T
Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection.
Radiat Oncol. 2018; 13(1):28
Doi: 10.1186/s13014-018-0974-5
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Korrektur
** Gkika, E; Vach, W; Adebahr, S; Schimek-Jasch, T; Brenner, A; Brunner, TB; Kaier, K; Prasse, A; Muller-Quernheim, J; Grosu, AL; Zissel, G; Nestle, U
Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? (vol 12, e0185350, 2017)
PLOS ONE. 2018; 13(1): e0192058
Doi: 10.1371/journal.pone.0192058
Web of Science
FullText
FullText_MUG
** Gkika, E; Vach, W; Adebahr, S; Schimek-Jasch, T; Brenner, A; Brunner, TB; Kaier, K; Prasse, A; Müller-Quernheim, J; Grosu, AL; Zissel, G; Nestle, U
Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
PLoS One. 2018; 13(1):e0192058
Doi: 10.1371/journal.pone.0192058
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Kommentar
** Boda-Heggemann, J; Gkika, E; Andratschke, N; Blanck, O; Guckenberger, M; Lohr, F; Brunner, TB
Correspondence on Rajyaguru et al.
J Clin Oncol. 2018; 36(24):2561-2562
Doi: 10.1200/JCO.2018.78.1542
Web of Science
PubMed
FullText
FullText_MUG
2017
Originalarbeit (Zeitschrift)
** Bettinger, D; Spode, R; Glaser, N; Buettner, N; Boettler, T; Neumann-Haefelin, C; Brunner, TB; Gkika, E; Maruschke, L; Thimme, R; Schultheiss, M
Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
BMC Gastroenterol. 2017; 17(1):98
Doi: 10.1186/s12876-017-0656-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Adebahr, S; Kirste, S; Schimek-Jasch, T; Wiehle, R; Claus, R; Wittel, U; Nestle, U; Baltas, D; Grosu, AL; Brunner, TB
Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
Strahlenther Onkol. 2017; 193(6):433-443
Doi: 10.1007/s00066-017-1099-8
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Hallauer, L; Kirste, S; Adebahr, S; Bartl, N; Neeff, HP; Fritsch, R; Brass, V; Nestle, U; Grosu, AL; Brunner, TB
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
BMC Cancer. 2017; 17(1):781
Doi: 10.1186/s12885-017-3788-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Schultheiss, M; Bettinger, D; Maruschke, L; Neeff, HP; Schulenburg, M; Adebahr, S; Kirste, S; Nestle, U; Thimme, R; Grosu, AL; Brunner, TB
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
Radiat Oncol. 2017; 12(1):116
Doi: 10.1186/s13014-017-0851-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Tanadini-Lang, S; Kirste, S; Holzner, PA; Neeff, HP; Rischke, HC; Reese, T; Lohaus, F; Duma, MN; Dieckmann, K; Semrau, R; Stockinger, M; Imhoff, D; Kremers, N; Häfner, MF; Andratschke, N; Nestle, U; Grosu, AL; Guckenberger, M; Brunner, TB
Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO).
Strahlenther Onkol. 2017; 193(10):823-830
Doi: 10.1007/s00066-017-1177-y
Web of Science
PubMed
FullText
FullText_MUG
** Gkika, E; Vach, W; Adebahr, S; Schimek-Jasch, T; Brenner, A; Brunner, TB; Kaier, K; Prasse, A; Müller-Quernheim, J; Grosu, AL; Zissel, G; Nestle, U
Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
PLoS One. 2017; 12(9):e0185350
Doi: 10.1371/journal.pone.0185350
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hoeppner, J; Glatz, T; Claus, R; Fischer, A; Kraywinkel, K; Brunner, T
[Esophageal Adenocarcinoma - Appraisal of a Rapidly Increasing Disease].
Dtsch Med Wochenschr. 2017; 142(19):1453-1460
Doi: 10.1055/s-0043-115777
Web of Science
PubMed
FullText
FullText_MUG
** Klement, RJ; Guckenberger, M; Alheid, H; Allgäuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Gerum, S; Habermehl, D; Hildebrandt, G; Lewitzki, V; Ostheimer, C; Papachristofilou, A; Petersen, C; Schneider, T; Semrau, R; Wachter, S; Andratschke, N
Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control.
Radiother Oncol. 2017; 123(2):227-233
Doi: 10.1016/j.radonc.2017.01.013
Web of Science
PubMed
FullText
FullText_MUG
** Wilson, JM; Mukherjee, S; Brunner, TB; Partridge, M; Hawkins, MA
Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy.
Clin Oncol (R Coll Radiol). 2017; 29(6):370-377
Doi: 10.1016/j.clon.2017.01.038
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Allam, A; Thomsen, AR; Gothwal, M; Saha, D; Maurer, J; Brunner, TB
Pancreatic stellate cells in pancreatic cancer: In focus.
Pancreatology. 2017; 17(4):514-522
Doi: 10.1016/j.pan.2017.05.390
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Gkika, E; Bettinger, D; Krafft, L; Schultheiss, M; Neeff, HP; Schulenburg, M; Adebahr, S; Kirste, S; Nestle, U; Thimme, R; Grosu, AL; Brunner, TB
The Role of different prognostic Scores in the hepatocellular Carcinoma Therapy
STRAHLENTHER ONKOL. 2017; 193: S57-S57.
Web of Science
** Gkika, E; Hallauer, L; Kirste, S; Adebahr, S; Bartl, N; Neeff, HP; Fritsch, R; Brass, V; Nestla, U; Grosu, AL; Brunner, TB
The Stereotactic Radiotherapy for treating Patients with locally advanced Cholangiocarcinoma
STRAHLENTHER ONKOL. 2017; 193: S44-S45.
Web of Science
** Gkika, E; Kirste, S; Adebahr, S; Neeff, HP; Schultheiss, M; Nestle, U; Grosu, AL; Brunner, TB
Liver Re-Irradiation of Patients with recurrent primary and secondary Liver Cancer, using SBRT. A Toxicity Analysis
STRAHLENTHER ONKOL. 2017; 193: S57-S57.
Web of Science
2016
Originalarbeit (Zeitschrift)
** Al-Assar, O; Bittner, MI; Lunardi, S; Stratford, MR; McKenna, WG; Brunner, TB
The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells.
Radiother Oncol. 2016; 119(2):300-5
Doi: 10.1016/j.radonc.2016.03.024
Web of Science
PubMed
FullText
FullText_MUG
** Hoeppner, J; Lordick, F; Brunner, T; Glatz, T; Bronsert, P; Röthling, N; Schmoor, C; Lorenz, D; Ell, C; Hopt, UT; Siewert, JR
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
BMC Cancer. 2016; 16:503
Doi: 10.1186/s12885-016-2564-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wilson, JM; Fokas, E; Dutton, SJ; Patel, N; Hawkins, MA; Eccles, C; Chu, KY; Durrant, L; Abraham, AG; Partridge, M; Woodward, M; O'Neill, E; Maughan, T; McKenna, WG; Mukherjee, S; Brunner, TB
ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.
Radiother Oncol. 2016; 119(2):306-11
Doi: 10.1016/j.radonc.2016.03.021
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Adebahr, S; Schimek-Jasch, T; Nestle, U; Brunner, TB
Oesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignancies.
Best Pract Res Clin Gastroenterol. 2016; 30(4):565-80
Doi: 10.1016/j.bpg.2016.07.003
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB
The rationale of combined radiotherapy and chemotherapy - Joint action of Castor and Pollux.
Best Pract Res Clin Gastroenterol. 2016; 30(4):515-28
Doi: 10.1016/j.bpg.2016.07.002
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Seufferlein, T
Pancreatic cancer chemoradiotherapy.
Best Pract Res Clin Gastroenterol. 2016; 30(4):617-28
Doi: 10.1016/j.bpg.2016.08.001
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Seufferlein, T
Radiation therapy in cholangiocellular carcinomas.
Best Pract Res Clin Gastroenterol. 2016; 30(4):593-602
Doi: 10.1016/j.bpg.2016.08.003
Web of Science
PubMed
FullText
FullText_MUG
** Panje, C; Andratschke, N; Brunner, TB; Niyazi, M; Guckenberger, M
Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
Strahlenther Onkol. 2016; 192(12):875-885
Doi: 10.1007/s00066-016-1053-1
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Brunner, TB; Seufferlein, T
Chemoradiotherapy, the backbone of radiotherapy in gastrointestinal oncology.
Best Pract Res Clin Gastroenterol. 2016; 30(4):511-3
Doi: 10.1016/j.bpg.2016.08.004
Web of Science
PubMed
FullText
FullText_MUG
Fallbericht
** Brunner, TB; Nestle, U; Adebahr, S; Gkika, E; Wiehle, R; Baltas, D; Grosu, AL
Simultaneous integrated protection : A new concept for high-precision radiation therapy.
Strahlenther Onkol. 2016; 192(12):886-894
Doi: 10.1007/s00066-016-1057-x
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, TB; Ernst, I; Blanck, O; Andratschke, N; Lewitzki, V; Ganswindt, U; Wachter, S; Alheit, H; Gkika, E; Guckenberger, M
Stereotactic body radiotherapy in hepatocellular and cholangiocellular carcinoma (HCC, CCC): First results of the German Society of Radiation Oncology (DEGRO) working group "stereotactic therapy" cohort.
ONCOL RES TREAT. 2016; 39: 165-166.
Web of Science
** Brunner, TB; Ernst, I; Blanck, O; Andratschke, N; Liwitzki, V; Ganswindt, U; Wachter, S; Alheid, H; Gkika, E; Guckenberger, M
Stereotactic body radiotherapy in hepatocellular and cholangiocellular carcinoma (HCC, CCC): First results of the German Society of Radiation Oncology (DEGRO) working group "stereotactic therapy" cohort
STRAHLENTHER ONKOL. 2016; 192: 25-26.
Web of Science
** Schnell, D; Grosu, AL; Brunner, TB
Long-term Survival through aggressive Therapeutic Strategies in Patients with anaplastic Thyroid Cancer and metachronous Metastasis - A Case Report
STRAHLENTHER ONKOL. 2016; 192: 70-70.
Web of Science
** Zipfel, AS; Grosu, AL; Brunner, TB
SBRT (stereotactic body radiation therapy) for treating Patients with primary inoperable malignant perivascular epithelioid cell Tumor (PEComa) of the Liver and followed by the Resection - A Case Report
STRAHLENTHER ONKOL. 2016; 192: 139-140.
Web of Science
Kommentar
** Brunner, T; Fokas, E
[The results of the LAP07 trial should not be misunderstood as the end of chemoradiotherapy in pancreatic cancer].
Strahlenther Onkol. 2016; 192(12):956-958
Doi: 10.1007/s00066-016-1058-9
Web of Science
PubMed
FullText
FullText_MUG
2015
Originalarbeit (Zeitschrift)
** Bittner, MI; Grosu, AL; Brunner, TB
Comparison of toxicity after IMRT and 3D-conformal radiotherapy for patients with pancreatic cancer - a systematic review.
Radiother Oncol. 2015; 114(1):117-21
Doi: 10.1016/j.radonc.2014.11.043
Web of Science
PubMed
FullText
FullText_MUG
** Chang, DT; Brunner, T; Cheng, JC; Liauw, SL; Meyer, J; Wo, JY
Randomized trials and new directions in gastrointestinal cancer.
Int J Radiat Oncol Biol Phys. 2015; 91(3):459-64
Doi: 10.1016/j.ijrobp.2014.10.015
Web of Science
PubMed
FullText
FullText_MUG
** Chang, DT; Jabbour, SK; Brunner, T; Cheng, JC; Liauw, SL; Meyer, J; Wo, J
Key New Studies in Gastric and Esophageal Cancer.
Int J Radiat Oncol Biol Phys. 2015; 93(3):475-81
Doi: 10.1016/j.ijrobp.2015.05.045
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Chirindel, A; Adebahr, S; Schuster, D; Schimek-Jasch, T; Schanne, DH; Nemer, U; Mix, M; Meyer, P; Grosu, AL; Brunner, T; Nestle, U
Impact of 4D-(18)FDG-PET/CT imaging on target volume delineation in SBRT patients with central versus peripheral lung tumors. Multi-reader comparative study.
Radiother Oncol. 2015; 115(3):335-41
Doi: 10.1016/j.radonc.2015.05.019
Web of Science
PubMed
FullText
FullText_MUG
** Chu, KY; Eccles, CL; Brunner, TB
Endobiliary Stent Position Changes during External-beam Radiotherapy.
J Med Imaging Radiat Sci. 2015; 46(1):57-64
Doi: 10.1016/j.jmir.2014.08.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Glatz, T; Marjanovic, G; Zirlik, K; Brunner, T; Hopt, UT; Makowiec, F; Hoeppner, J
[Surgical treatment of esophageal cancer : Evolution of management and prognosis over the last 3 decades].
Chirurg. 2015; 86(7):662-9
Doi: 10.1007/s00104-014-2877-9
Web of Science
PubMed
FullText
FullText_MUG
** Golcher, H; Brunner, TB; Witzigmann, H; Marti, L; Bechstein, WO; Bruns, C; Jungnickel, H; Schreiber, S; Grabenbauer, GG; Meyer, T; Merkel, S; Fietkau, R; Hohenberger, W
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial.
Strahlenther Onkol. 2015; 191(1):7-16
Doi: 10.1007/s00066-014-0737-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lunardi, S; Lim, SY; Muschel, RJ; Brunner, TB
IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer.
Oncoimmunology. 2015; 4(9):e1027473
Doi: 10.1080/2162402X.2015.1027473
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schultheiß, M; Bettinger, D; Neeff, HP; Brunner, TB; Thimme, R
[Hepatocellular Carcinoma: therapeutic options 2015].
Dtsch Med Wochenschr. 2015; 140(14):1063-8
Doi: 10.1055/s-0041-102333
Web of Science
PubMed
FullText
FullText_MUG
** Seehofer, D; Brunner, TB; Wege, H
Current therapy concepts for local cholangiocarcinoma
ONKOLOGE. 2015; 21(11): 1054-1063.
Doi: 10.1007/s00761-015-2931-3
Web of Science
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB; Nestle, U; Grosu, AL; Partridge, M
SBRT in pancreatic cancer: what is the therapeutic window?
Radiother Oncol. 2015; 114(1):109-16
Doi: 10.1016/j.radonc.2014.10.015
Web of Science
PubMed
FullText
FullText_MUG
** Takaori, K; Bassi, C; Biankin, A; Brunner, TB; Cataldo, I; Campbell, F; Cunningham, D; Falconi, M; Frampton, AE; Furuse, J; Giovannini, M; Jackson, R; Nakamura, A; Nealon, W; Neoptolemos, JP; Real, FX; Scarpa, A; Sclafani, F; Windsor, JA; Yamaguchi, K; Wolfgang, C; Johnson, CD, , IAP/EPC, study, group, on, the, clinical, managements, of, pancreatic, cancer
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer.
Pancreatology. 2015; 16(1):14-27
Doi: 10.1016/j.pan.2015.10.013
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Vogel, A; Brunner, TB; Werner, J
Diagnosis and Therapy of Pancreatic Cancer and Cholangiocarcinoma
ONKOLOGE. 2015; 21(11): 1009-1010.
Doi: 10.1007/s00761-015-2926-0
Web of Science
FullText
FullText_MUG
Fallbericht
** Zamboglou, C; Bronsert, P; Küsters, S; Salm, N; Azèmar, M; Brunner, T
Radiotherapy for SMAD4-negative musculoskeletal lesions from pancreatic cancer: case report and review.
Strahlenther Onkol. 2015; 191(1):67-72
Doi: 10.1007/s00066-014-0764-4
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, TB; Wiehle, R; Kirste, S; Rohner, F; Prokic, V; Grosu, AL; Nestle, U
SIB-SIP: Combined simultaneous integrated boost and protection for upper abdominal SBRT
RADIOTHER ONCOL. 2015; 115: S388-S389.
Web of Science
** Thomsen, AR; Aldrian, C; Melin, N; Heselich, A; Niedermann, G; Brunner, TB
Stromal Cells as supportive and as inhibiting Factor-3D-Cultures with Pancreatic Cancer Cells
STRAHLENTHER ONKOL. 2015; 191: S78-S78.
Web of Science
** Wilson, JM; Mukherjee, S; Brunner, TB; Partridge, M; Hawkins, MA
The Application of Pre and Post Chemoradiation Therapy FDG-PET/CT to Treatment Strategy Selection in Locally Advanced Pancreatic Cancer
INT J RADIAT ONCOL. 2015; 93(3): E130-E131.
Doi: 10.1016/j.ijrobp.2015.07.880
Web of Science
FullText
FullText_MUG
** Wilson, JM; Mukherjee, S; Grimes, DR; Durrant, L; Brunner, TB; Partridge, M; Hawkins, MA
Fluoromisonidazole-PET/CT in pancreatic cancer: moving towards hypoxic biological target volume definition
RADIOTHER ONCOL. 2015; 115: S343-S344.
Web of Science
Kommentar
** Feng, M; Brunner, TB; Ben-Josef, E
Stereotactic Body Radiation Therapy for Liver Cancer: Effective Therapy With Minimal Impact on Quality of Life.
Int J Radiat Oncol Biol Phys. 2015; 93(1):26-8
Doi: 10.1016/j.ijrobp.2015.06.045
Web of Science
PubMed
FullText
FullText_MUG
2014
Originalarbeit (Zeitschrift)
** Al-Assar, O; Demiciorglu, F; Lunardi, S; Gaspar-Carvalho, MM; McKenna, WG; Muschel, RM; Brunner, TB
Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cells.
Radiother Oncol. 2014; 111(2):243-51
Doi: 10.1016/j.radonc.2014.03.014
Web of Science
PubMed
FullText
FullText_MUG
** Chang, DT; Brunner, T; Cheng, JC; Liauw, S; Meyer, J; Wo, J
Oncology scan-novel treatment strategies for gastrointestinal cancers.
Int J Radiat Oncol Biol Phys. 2014; 89(4):699-703
Doi: 10.1016/j.ijrobp.2014.01.048
Web of Science
PubMed
FullText
FullText_MUG
** Hoeppner, J; Zirlik, K; Brunner, T; Bronsert, P; Kulemann, B; Sick, O; Marjanovic, G; Hopt, UT; Makowiec, F
Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
J Surg Oncol. 2014; 109(3):287-93
Doi: 10.1002/jso.23498
Web of Science
PubMed
FullText
FullText_MUG
** Lunardi, S; Jamieson, NB; Lim, SY; Griffiths, KL; Carvalho-Gaspar, M; Al-Assar, O; Yameen, S; Carter, RC; McKay, CJ; Spoletini, G; D'Ugo, S; Silva, MA; Sansom, OJ; Janssen, KP; Muschel, RJ; Brunner, TB
IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival.
Oncotarget. 2014; 5(22):11064-80
Doi: 10.18632/oncotarget.2519
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sterzing, F; Brunner, TB; Ernst, I; Baus, WW; Greve, B; Herfarth, K; Guckenberger, M
Stereotactic body radiotherapy for liver tumors Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy
STRAHLENTHER ONKOL. 2014; 190(10): 872-881.
Doi: 10.1007/s00066-014-0714-1
Web of Science
PubMed
FullText
FullText_MUG
** Wilson, JM; Mukherjee, S; Chu, KY; Brunner, TB; Partridge, M; Hawkins, M
Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer.
Radiat Oncol. 2014; 9:146
Doi: 10.1186/1748-717X-9-146
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Fokas, E; Prevo, R; Hammond, EM; Brunner, TB; McKenna, WG; Muschel, RJ
Targeting ATR in DNA damage response and cancer therapeutics.
Cancer Treat Rev. 2014; 40(1):109-17
Doi: 10.1016/j.ctrv.2013.03.002
Web of Science
PubMed
FullText
FullText_MUG
** Lunardi, S; Muschel, RJ; Brunner, TB
The stromal compartments in pancreatic cancer: are there any therapeutic targets?
Cancer Lett. 2014; 343(2):147-55
Doi: 10.1016/j.canlet.2013.09.039
Web of Science
PubMed
FullText
FullText_MUG
** Skripcak, T; Belka, C; Bosch, W; Brink, C; Brunner, T; Budach, V; Büttner, D; Debus, J; Dekker, A; Grau, C; Gulliford, S; Hurkmans, C; Just, U; Krause, M; Lambin, P; Langendijk, JA; Lewensohn, R; Lühr, A; Maingon, P; Masucci, M; Niyazi, M; Poortmans, P; Simon, M; Schmidberger, H; Spezi, E; Stuschke, M; Valentini, V; Verheij, M; Whitfield, G; Zackrisson, B; Zips, D; Baumann, M
Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets.
Radiother Oncol. 2014; 113(3):303-9
Doi: 10.1016/j.radonc.2014.10.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Aldrian, C; Melin, N; Zamboglou, C; Nanko, N; Niedermann, G; Brunner, TB; Thomsen, AR
Agarose-based Ko-Kultures of Tumor- and Stromal Cells - a 3D-Model for Tadiation Biology
STRAHLENTHER ONKOL. 2014; 190: 81-81.
Web of Science
** Bittner, MI; Grosu, AL; Brunner, TB
Comparison of the toxicity of t versus three-dimensional conformal radiotherapy intnsity tsmodulierter in pancreatic cancer
STRAHLENTHER ONKOL. 2014; 190: 33-34.
Web of Science
** Bittner, MI; Grosu, AL; Brunner, TB
Pancreatic cancer: Comparison of toxicity of IMRT and 3D-conformal radiotherapy (3D-CRT)
RADIOTHER ONCOL. 2014; 111: S115-S115.
Web of Science
** Brunner, TB; Grosu, AL; Nestle, U; Partridge, M
Stereotactic body radiotherapy (SBRT) in pancreatic cancer: What is the therapeutic window?
STRAHLENTHER ONKOL. 2014; 190: 11-11.
Web of Science
** Brunner, TB; Kirste, S; Nestle, U; Grosu, AL; Wiehle, R
SIP (Simultaneous Integrated Protection Volume)-Concept for the SBRT in Patients with Pancreatic Carcinoma
STRAHLENTHER ONKOL. 2014; 190: 122-122.
Web of Science
** Brunner, TB; Kirste, S; Schultheiss, M; Euringer, W; Neeff, H; Schulenburg, M; Thimme, R; Grosu, AL
Stereotactical Radiotherapy in the Hepatocellular Carcinoma (HCC). A single-center Phase II Study
STRAHLENTHER ONKOL. 2014; 190: 10-11.
Web of Science
** Brunner, TB; Nestle, U; Grosu, AL; Partridge, M
Stereotactic body radiotherapy (SBRT) in pancreatic cancer: What is the therapeutic window?
RADIOTHER ONCOL. 2014; 111: S100-S100.
Web of Science
** Brunner, TB; Wilson, J; Mukherjee, S; Chu, KY; Partridge, M; Hawkins, M
Approaches for Use of the 18 F-Fluorodeoxyglucose-PET CT to Define a biological Boost Volume in locally advanced Pancreatic Carcinoma
STRAHLENTHER ONKOL. 2014; 190: 91-91.
Web of Science
** Chu, K; Eccles, CL; Warren, S; Brunner, TB; Mukherjee, S; Hawkins, M
Impact of Weight Change on Dose Delivery in Pancreatic Intensity Modulated Radiation Therapy
INT J RADIAT ONCOL. 2014; 90: S862-S863.
Doi: 10.1016/j.ijrobp.2014.05.2466
Web of Science
FullText
FullText_MUG
** Kirste, S; Trautsch, H; Messmer, B; Grosu, AL; Momm, F; Brunner, TB
Upper abdominal stereotactic radiotherapy (SBRT): Correlation of local control with biological equivalent dose
RADIOTHER ONCOL. 2014; 111: S117-S117.
Web of Science
** Lunardi, S; Jamieson, NB; Griffiths, KL; Carvalho-Gaspar, MM; Lim, SY; Al-Assar, O; Carter, RC; Mckay, CJ; Silva, MA; Janssen, KP; Muschel, RJ; Brunner, TB
IP-10/CXCL10 expression is induced in tumor stroma in pancreatic cancer and correlates with poor survival in patients
STRAHLENTHER ONKOL. 2014; 190: 77-77.
Web of Science
** Thomsen, AR; Aldrian, C; Melin, N; Heselich, A; Barent, C; Wiedenmann, N; Rucker, G; Niedermann, G; Brunner, TB
Klonogenes Survival: A simplified Limiting Dilution Method as an Alternative to classical Colony forming-Assays
STRAHLENTHER ONKOL. 2014; 190: 83-83.
Web of Science
** Wilson, JM; Mukherjee, S; Chu, KY; Brunner, TB; Partridge, M; Hawkins, MA
Biological target volume definition in locally advanced pancreatic cancer: how useful is FDG-PET?
RADIOTHER ONCOL. 2014; 111: S26-S26.
Web of Science
Kommentar
** Brunner, TB
[Is D2 and D1 lymphadenectomy for patients with gastric cancer beneficial?].
Strahlenther Onkol. 2014; 190(6):592-3
Doi: 10.1007/s00066-014-0623-3
Web of Science
PubMed
FullText
FullText_MUG
2013
Originalarbeit (Zeitschrift)
** Fokas, E; Eccles, C; Patel, N; Chu, KY; Warren, S; Gillies, McKenna, W; Brunner, TB
Comparison of four target volume definitions for pancreatic cancer. Guidelines for treatment of the lymphatics and the primary tumor.
Strahlenther Onkol. 2013; 189(5):407-16
Doi: 10.1007/s00066-013-0332-3
Web of Science
PubMed
FullText
FullText_MUG
** Fokas, E; Eccles, C; Patel, N; Chu, KY; Warren, S; McKenna, WG; Brunner, TB
A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapy.
Radiother Oncol. 2013; 107(2):200-6
Doi: 10.1016/j.radonc.2013.04.010
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Warren, S; Partridge, M; Fokas, E; Eccles, CL; Brunner, TB
Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancer.
Acta Oncol. 2013; 52(7):1573-8
Doi: 10.3109/0284186X.2013.813072
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB
Neoadjuvant therapy for potentially resectable pancreatic cancer: an emerging paradigm?
Curr Oncol Rep. 2013; 15(2):162-9
Doi: 10.1007/s11912-012-0291-3
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, TB; Golcher, H; Witzigmann, H; Marti, L; Bechstein, WO; Bruns, C; Jungnickel, H; Schreiber, S; Grabenbauer, GG; Meyer, T; Merkel, S; Fietkau, R; Hohenberger, W
Preoperative chemoradiation for resectable adenocarcinoma of pancreatic head: results of a randomized phase-II trial
STRAHLENTHER ONKOL. 2013; 189: 18-18.
Web of Science
** Fokas, E; Eccles, CE; Patel, N; Chu, KY; Warren, S; McKenna, WG; Brunner, TB
A comprehensive dosimetric comparison of four target volume definitions for pancreatic cancer and their influence on lymphatics and organs at risk
STRAHLENTHER ONKOL. 2013; 189: 96-96.
Web of Science
** Fokas, E; Prevo, R; Pollard, JR; Reaper, PM; Charlton, P; Cornelissen, B; Vallis, K; Hammond, EM; Olcina, MM; McKenna, WG; Muschel, RJ; Brunner, TB
ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
STRAHLENTHER ONKOL. 2013; 189: 41-41.
Web of Science
** Schanne, DH; Kuchler, S; Henke, M; Rischke, HC; Grosu, AL; Brunner, TB
Comparison of two contouring techniques for small bowel delineation in rectal and anal cancer
STRAHLENTHER ONKOL. 2013; 189: 94-94.
Web of Science
2012
Originalarbeit (Zeitschrift)
** Fokas, E; Prevo, R; Pollard, JR; Reaper, PM; Charlton, PA; Cornelissen, B; Vallis, KA; Hammond, EM; Olcina, MM; Gillies, McKenna, W; Muschel, RJ; Brunner, TB
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
Cell Death Dis. 2012; 3:e441
Doi: 10.1038/cddis.2012.181
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Leach, MO; Morgan, B; Tofts, PS; Buckley, DL; Huang, W; Horsfield, MA; Chenevert, TL; Collins, DJ; Jackson, A; Lomas, D; Whitcher, B; Clarke, L; Plummer, R; Judson, I; Jones, R; Alonzi, R; Brunner, T; Koh, DM; Murphy, P; Waterton, JC; Parker, G; Graves, MJ; Scheenen, TW; Redpath, TW; Orton, M; Karczmar, G; Huisman, H; Barentsz, J; Padhani, A, , Experimental, Cancer, Medicine, Centres, Imaging, Network, Steering, Committee
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.
Eur Radiol. 2012; 22(7):1451-64
Doi: 10.1007/s00330-012-2446-x
Web of Science
PubMed
FullText
FullText_MUG
** Miles, KA; Lee, TY; Goh, V; Klotz, E; Cuenod, C; Bisdas, S; Groves, AM; Hayball, MP; Alonzi, R; Brunner, T, , Experimental, Cancer, Medicine, Centre, Imaging, Network, Group
Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography.
Eur Radiol. 2012; 22(7):1430-41
Doi: 10.1007/s00330-012-2379-4
Web of Science
PubMed
FullText
FullText_MUG
** Prevo, R; Fokas, E; Reaper, PM; Charlton, PA; Pollard, JR; McKenna, WG; Muschel, RJ; Brunner, TB
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
Cancer Biol Ther. 2012; 13(11):1072-81
Doi: 10.4161/cbt.21093
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB; Kunz-Schughart, LA; Grosse-Gehling, P; Baumann, M
Cancer stem cells as a predictive factor in radiotherapy.
Semin Radiat Oncol. 2012; 22(2):151-74
Doi: 10.1016/j.semradonc.2011.12.003
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, TB; Hill, E; Wilson, J; Maughan, T; Eccles, C; McKenna, WG
NELFINAVIR AND RT IN PANCREATIC CANCER
RADIOTHER ONCOL. 2012; 104: 29-29.
Doi: 10.1016/S0167-8140(15)34582-5
Web of Science
FullText
FullText_MUG
Kommentar
** Brunner, T
[Despite of the updated analysis of the SWOG-directed Intergroup Study 0116, adjuvant radiochemotherapy is not yet the standard for gastric cancer after curative resection].
Strahlenther Onkol. 2012; 188(11):1052-3
Doi: 10.1007/s00066-012-0218-9
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, T
[Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis].
Strahlenther Onkol. 2012; 188(4):366-7
Doi: 10.1007/s00066-012-0079-2
Web of Science
PubMed
FullText
FullText_MUG
2011
Originalarbeit (Zeitschrift)
** Al-Assar, O; Mantoni, T; Lunardi, S; Kingham, G; Helleday, T; Brunner, TB
Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G2 fraction.
Cancer Biol Ther. 2011; 11(12):1028-35
Doi: 10.4161/cbt.11.12.15699
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Sauer, R; Fietkau, R
Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients.
Radiat Oncol. 2011; 6:88
Doi: 10.1186/1748-717X-6-88
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mantoni, TS; Lunardi, S; Al-Assar, O; Masamune, A; Brunner, TB
Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling.
Cancer Res. 2011; 71(10):3453-8
Doi: 10.1158/0008-5472.CAN-10-1633
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Harrington, KJ; Billingham, LJ; Brunner, TB; Burnet, NG; Chan, CS; Hoskin, P; Mackay, RI; Maughan, TS; Macdougall, J; McKenna, WG; Nutting, CM; Oliver, A; Plummer, R; Stratford, IJ; Illidge, T
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.
Br J Cancer. 2011; 105(5):628-39
Doi: 10.1038/bjc.2011.240
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Brunner, T; McKenna, G
Combining molecular targeted therapeutics (MTT) and radiotherapy: MTT and MTD.
Eur J Cancer. 2011; 47 Suppl 3:S373-4
Doi: 10.1016/S0959-8049(11)70208-8
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Al-Assar, O; Mantoni, TS; Lunardi, S; Kingham, G; Helleday, T; Brunner, TB
Breast cancer stem-like cells show enhanced homologous recombination due to a larger S-G2 fraction
STRAHLENTHER ONKOL. 2011; 187: 54-54.
Web of Science
** Eccles, CL; Vallis, KA; Brunner, TB; McKenna, WG
Comparison of Locally Advanced Pancreatic Cancer Target Definition Methods on 18FDG-PET images for Radiotherapy Treatment Planning
INT J RADIAT ONCOL. 2011; 81(2): S732-S732.
Doi: 10.1016/j.ijrobp.2011.06.1305
Web of Science
FullText
FullText_MUG
** Eccles, CL; Vallis, KA; McKenna, WG; Brunner, TB
A Comparison of contrast-reinforced lever Computed tomography (CECT) with FDG-PET-based Target volume definition in locally advanced Pancreatic Cancer (LAPC) for conventional and adaptive Radiochemotherapy (RCT)
STRAHLENTHER ONKOL. 2011; 187: 39-39.
Web of Science
** Eccles, CL; Vallis, KA; McKenna, WG; Brunner, TB
Potential advantages and tradeoffs of intensity modulated radiotherapy for locally advanced pancreas cancer (including elective nodal volumes)
STRAHLENTHER ONKOL. 2011; 187: 39-39.
Web of Science
** Mantoni, TS; Lunardi, S; McKenna, WG; Brunner, TB
The Interaction of pancreatic Cancer and Stellate Cells as a Mediator of Radiation Resistance in ductal Pancreatic Adenocarcinoma
STRAHLENTHER ONKOL. 2011; 187: 38-39.
Web of Science
Guideline/Konsensuspapier
** Eckel, F; Brunner, T; Jelic, S, , ESMO, Guidelines, Working, Group
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2011; 22 Suppl 6:vi40-4
Doi: 10.1093/annonc/mdr375
Web of Science
PubMed
FullText
FullText_MUG
2010
Übersichtsarbeit
** Brunner, TB; Eccles, CL
Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.
Strahlenther Onkol. 2010; 186(12):672-80
Doi: 10.1007/s00066-010-2161-y
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Scott-Brown, M
The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
Radiat Oncol. 2010; 5:64
Doi: 10.1186/1748-717X-5-64
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Editorial
** Maughan, TS; Illidge, TM; Hoskin, P; McKenna, WG; Brunner, TB; Stratford, IJ; Harrington, KJ; Plummer, R; Billingham, LJ; Nutting, C; Burnet, NG; Mackay, RI; Oliver, A; Young, C; Chan, CS, , NCRI, Clinical, and, Translational, Radiotherapy, Research, Working, Group
Radiotherapy research priorities for the UK.
Clin Oncol (R Coll Radiol). 2010; 22(8):707-9
Doi: 10.1016/j.clon.2010.03.006
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Lunardi, S; Mantoni, T; Al-Assar, O; Brunner, TB
Pancreatic stellate cells modify tumour growth and radioresponse of pancreatic cancer
EJC SUPPL. 2010; 8(5): 211-211.
Doi: 10.1016/S1359-6349(10)71631-1
Web of Science
FullText
FullText_MUG
Guideline/Konsensuspapier
** Eckel, F; Brunner, T; Jelic, S, , ESMO, Guidelines, Working, Group
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2010; 21 Suppl 5:v65-9
Doi: 10.1093/annonc/mdq167
Web of Science
PubMed
FullText
FullText_MUG
2009
Originalarbeit (Zeitschrift)
** Al-Assar, O; Muschel, RJ; Mantoni, TS; McKenna, WG; Brunner, TB
Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers.
Int J Radiat Oncol Biol Phys. 2009; 75(4):1216-25
Doi: 10.1016/j.ijrobp.2009.07.001
Web of Science
PubMed
FullText
FullText_MUG
** Tinkl, D; Grabenbauer, GG; Golcher, H; Meyer, T; Papadopoulos, T; Hohenberger, W; Sauer, R; Brunner, TB
Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
Strahlenther Onkol. 2009; 185(9):557-66
Doi: 10.1007/s00066-009-1977-9
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, TB; Al-Assar, O; Muschel, RJ; Mantoni, TS; McKenna, WG
The Radiation Response of Cancer Stem Cell-like Subpopulations from Established Human Cell Lines
INT J RADIAT ONCOL. 2009; 75(3): S19-S19.
Doi: 10.1016/j.ijrobp.2009.07.066
Web of Science
FullText
FullText_MUG
** Brunner, TB; Al-Assar, O; Muschel, RJ; Mantoni, TS; McKenna, WG
Die hard? Radiation sensitivity of cancer stem cells from established human cell lines
EJC SUPPL. 2009; 7(2): 153-153.
Doi: 10.1016/S1359-6349(09)70521-X
Web of Science
FullText
FullText_MUG
2008
Originalarbeit (Zeitschrift)
** Brunner, TB; Geiger, M; Grabenbauer, GG; Lang-Welzenbach, M; Mantoni, TS; Cavallaro, A; Sauer, R; Hohenberger, W; McKenna, WG
Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
J Clin Oncol. 2008; 26(16):2699-706
Doi: 10.1200/JCO.2007.15.2355
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Rupp, A; Melzner, W; Grabenbauer, GG; Sauer, R
Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
Strahlenther Onkol. 2008; 184(1):15-22
Doi: 10.1007/s00066-008-1787-5
Web of Science
PubMed
FullText
FullText_MUG
** Golcher, H; Brunner, T; Grabenbauer, G; Merkel, S; Papadopoulos, T; Hohenberger, W; Meyer, T
Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
Eur J Surg Oncol. 2008; 34(7):756-64
Doi: 10.1016/j.ejso.2007.11.012
Web of Science
PubMed
FullText
FullText_MUG
** Mantoni, TS; Schendel, RR; Rödel, F; Niedobitek, G; Al-Assar, O; Masamune, A; Brunner, TB
Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma.
Cancer Biol Ther. 2008; 7(11):1806-15
Doi: 10.4161/cbt.7.11.6846
Web of Science
PubMed
FullText
FullText_MUG
** Meier, I; Merkel, S; Papadopoulos, T; Sauer, R; Hohenberger, W; Brunner, TB
Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
Int J Radiat Oncol Biol Phys. 2008; 70(5):1408-17
Doi: 10.1016/j.ijrobp.2007.08.053
Web of Science
PubMed
FullText
FullText_MUG
** Semrau, R; Hansemann, K; Adam, M; Andratschke, N; Brunner, T; Heinzelmann, F; Hildebrandt, G; Vordermark, D; Zips, D
Quality of training in radiation oncology in Germany. Results of a 2006 survey.
Strahlenther Onkol. 2008; 184(5):239-44
Doi: 10.1007/s00066-008-1821-7
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Klautke, G; Brunner, TB
Radiotherapy in pancreatic cancer.
Strahlenther Onkol. 2008; 184(11):557-64
Doi: 10.1007/s00066-008-1865-8
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, TB; Geiger, M; Grabenbauer, GG; Mantoni, TS; Cavallaro, A; Sauer, R; Hohenberger, W; McKenna, WG
A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
J CLIN ONCOL. 2008; 26(15):
Doi: 10.1200/jco.2008.26.15_suppl.4632
Web of Science
FullText
FullText_MUG
** Cordes, N; Frick, S; Hehlgans, S; Brunner, TB; Pilarsky, C; Grutzmann, R; Bence, SBS; Kloppel, G; McKenna, WG; Bernhard, EJ
Knockdown of the integral membrane protein caveolin-1 sensitizes human pancreatic carcinoma cells to ionizing radiation
ONKOLOGIE. 2008; 31: 173-174.
Web of Science
Kommentar
** Bernhard, EJ; Brunner, TB
Progress towards the use of HIV protease inhibitors in cancer therapy.
Cancer Biol Ther. 2008; 7(5):636-7
Doi: 10.4161/cbt.7.5.6087
Web of Science
PubMed
FullText
FullText_MUG
2007
Originalarbeit (Zeitschrift)
** Brunner, TB; Grabenbauer, GG; Meyer, T; Golcher, H; Sauer, R; Hohenberger, W
Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO)
BMC CANCER. 2007; 7: 41
Doi: 10.1186/1471-2407-7-41
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Cengel, KA; Voong, KR; Chandrasekaran, S; Maggiorella, L; Brunner, TB; Stanbridge, E; Kao, GD; McKenna, WG; Bernhard, EJ
Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells
NEOPLASIA. 2007; 9(4): 341-348.
Doi: 10.1593/neo.06823
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Cordes, N; Frickz, S; Brunner, TB; Pilarsky, C; Grutzmann, R; Siposs, B; Kloppels, G; McKenna, WG; Bernhard, EJ
Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1
ONCOGENE. 2007; 26(48): 6851-6862.
Doi: 10.1038/sj.onc.1210498
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB; Sauer, R
The role of radiochemotherapy in multimodal therapy of pancreatic cancer
DEUT MED WOCHENSCHR. 2007; 132(15): 808-812.
Doi: 10.1055/s-2007-973625
Web of Science
PubMed
FullText
FullText_MUG
2006
Originalarbeit (Zeitschrift)
** Brueckl, WM; Herbst, L; Lechler, A; Fuchs, F; Schoeberl, A; Zirlik, S; Klein, P; Brunner, TB; Papadopoulos, T; Hohenberger, W; Hahn, EG; Wiest, GH
Predictive and prognostic factors in small cell lung carcinoma (SCLC) - Analysis from routine clinical practice
ANTICANCER RES. 2006; 26(6C): 4825-4832.
Web of Science
PubMed
** Brunner, TB; Baum, U; Grabenbauer, GG; Sauer, R; Lambrecht, U
Large topographic variability of upper abdominal lymphatics and the consequences for radiation treatment planning
RADIOTHER ONCOL. 2006; 81(2): 190-195.
Doi: 10.1016/j.radonc.2006.09.007
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Ernst-Stecken, A; Jeske, I; Grabenbauer, GG; Sauer, R; Distel, L
Molecular verification of stereotactic radiotherapy in rats using ATMpS1981 immunofluorescence
RADIOTHER ONCOL. 2006; 79(1): 109-114.
Doi: 10.1016/j.radonc.2006.01.010
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Tinkl, D; Grabenbauer, GG; Meyer, T; Brueckl, WM; Sauer, R
Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma - A retrospective analysis of prospectively recruited patients
STRAHLENTHER ONKOL. 2006; 182(4): 210-215.
Doi: 10.1007/s00066-006-1524-x
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Brunner, TB; Meier, I; Hermanek, P; Hohenberger, W; Sauer, R; Merkel, S
Adenocarcinoma of the esophagogastric (AEG) junction: Elective lymphatic target volume definition based on the pattern of metastatic lymph node dissemination
INT J RADIAT ONCOL. 2006; 66(3): S263-S263.
Doi: 10.1016/j.ijrobp.2006.07.500
Web of Science
FullText
FullText_MUG
2005
Originalarbeit (Zeitschrift)
** Brunner, TB; Cengel, KA; Hahn, SM; Wu, HM; Fraker, DL; McKenna, WG; Bernhard, EJ
Pancreatic cancer cell radiation survival and prenyltransferase inhibition: The role of K-ras
CANCER RES. 2005; 65(18): 8433-8441.
Doi: 10.1158/0008-5472.CAN-05-0158
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Merkel, S; Grabenbauer, GG; Meyer, T; Baum, U; Papadopoulos, T; Sauer, R; Hohenberger, W
Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysis
INT J RADIAT ONCOL. 2005; 62(4): 1021-1029.
Doi: 10.1016/j.ijrobp.2004.12.018
Web of Science
PubMed
FullText
FullText_MUG
2004
Originalarbeit (Zeitschrift)
** Brunner, TB; Schwab, D; Meyer, S; Sauer, R
Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma - A retrospective analysis
STRAHLENTHER ONKOL. 2004; 180(12): 751-757.
Doi: 10.1007/s00066-004-1315-1
Web of Science
PubMed
FullText
FullText_MUG
** Martin, NE; Brunner, TB; Kiel, KD; DeLaney, TF; Regine, WF; Mohiuddin, M; Rosato, EF; Haller, DG; Stevenson, JP; Smith, D; Pramanik, B; Tepper, J; Tanaka, WK; Morrison, B; Deutsch, P; Gupta, AK; Muschel, RJ; McKenna, WG; Bernhard, EJ; Hahn, SM
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer
CLIN CANCER RES. 2004; 10(16): 5447-5454.
Doi: 10.1158/1078-0432.CCR-04-0248
Web of Science
PubMed
FullText
FullText_MUG
** Schreiber, FS; Deramaudt, TB; Brunner, TB; Boretti, MI; Gooch, KJ; Stoffers, DA; Bernhard, EJ; Rustgi, AK
Successful growth and characterization of mouse pancreatic ductal cells: Functional properties of the Ki-RAS(G12V) oncogene
GASTROENTEROLOGY. 2004; 127(1): 250-260.
Doi: 10.1053/j.gastro.2004.03.058
Web of Science
PubMed
FullText
FullText_MUG
** Wendt, TG; Gademann, G; Pambor, C; Grießbach, I; von, Specht, H; Martin, T; Baltas, D; Kurek, R; Röddiger, S; Tunn, UW; Zamboglou, N; Eich, HT; Staar, S; Gossmann, A; Hansemann, K; Semrau, R; Skripnitchenko, R; Diehl, V; Müller, RP; Sehlen, S; Willich, N; Rühl, U; Lukas, P; Dühmke, E; Engel, K; Tabbert, E; Bolck, M; Knaack, S; Annweiler, H; Krempien, R; Hoppe, H; Harms, W; Daeuber, S; Schorr, O; Treiber, M; Debus, J; Alber, M; Paulsen, F; Birkner, M; Bakai, A; Belka, C; Budach, W; Grosser, KH; Kramer, R; Kober, B; Reinert, M; Schneider, P; Hertel, A; Feldmann, H; Csere, P; Hoinkis, C; Rothe, G; Zahn, P; Alheit, H; Cavanaugh, SX; Kupelian, P; Reddy, C; Pollock, B; Fuss, M; Roeddiger, S; Dannenberg, T; Rogge, B; Drechsler, D; Herrmann, T; Alberti, W; Schwarz, R; Graefen, M; Krüll, A; Rudat, V; Huland, H; Fehr, C; Baum, C; Glocker, S; Nüsslin, F; Heil, T; Lemnitzer, H; Knips, M; Baumgart, O; Thiem, W; Kloetzer, KH; Hoffmann, L; Neu, B; Hültenschmidt, B; Sautter-Bihl, ML; Micke, O; Seegenschmiedt, MH; Köppen, D; Klautke, G; Fietkau, R; Schultze, J; Schlichting, G; Koltze, H; Kimmig, B; Glatzel, M; Fröhlich, D; Bäsecke, S; Krauß, A; Strauß, D; Buth, KJ; Böhme, R; Oehler, W; Bottke, D; Keilholz, U; Heufelder, K; Wiegel, T; Hinkelbein, W; Rödel, C; Papadopoulos, T; Munnes, M; Wirtz, R; Sauer, R; Rödel, F; Lubgan, D; Distel, L; Grabenbauer, GG; Sak, A; Stüben, G; Pöttgen, C; Grehl, S; Stuschke, M; Müller, K; Pfaffendorf, C; Mayerhofer, A; Köhn, FM; Ring, J; van, Beuningen, D; Meineke, V; Neubauer, S; Keller, U; Wittlinger, M; Riesenbeck, D; Greve, B; Exeler, R; Ibrahim, M; Liebscher, C; Severin, E; Ott, O; Pötter, R; Hammer, J; Hildebrandt, G; Beckmann, MW; Strnad, V; Fehlauer, F; Tribius, S; Bajrovic, A; Höller, U; Rades, D; Warszawski, A; Baumann, R; Madry-Gevecke, B; Karstens, JH; Grehn, C; Hensley, F; Berns, C; Wannenmacher, M; Semrau, S; Reimer, T; Gerber, B; Ketterer, P; Koepcke, E; Hänsgen, G; Strauß, HG; Dunst, J; Füller, J; Kalb, S; Wendt, T; Weitmann, HD; Waldhäusl, C; Knocke, TH; Lamprecht, U; Classen, J; Kaulich, TW; Aydeniz, B; Bamberg, M; Wiezorek, T; Banz, N; Salz, H; Scheithauer, M; Schwedas, M; Lutterbach, J; Bartelt, S; Frommhold, H; Lambert, J; Hornung, D; Swiderski, S; Walke, M; Siefert, A; Pöllinger, B; Krimmel, K; Schaffer, M; Koelbl, O; Bratengeier, K; Vordermark, D; Flentje, M; Hero, B; Berthold, F; Combs, SE; Gutwein, S; Schulz-Ertner, D; van, Kampen, M; Thilmann, C; Kocher, M; Kunze, S; Schild, S; Ikezaki, K; Müller, B; Sieber, R; Weiß, C; Wolf, I; Wenz, F; Weber, KJ; Schäfer, J; Engling, A; Laufs, S; Veldwijk, MR; Milanovic, D; Fleckenstein, K; Zeller, W; Fruehauf, S; Herskind, C; Weinmann, M; Jendrossek, V; Rübe, C; Appold, S; Kusche, S; Hölscher, T; Brüchner, K; Geyer, P; Baumann, M; Kumpf, R; Zimmermann, F; Schill, S; Geinitz, H; Nieder, C; Jeremic, B; Molls, M; Liesenfeld, S; Petrat, H; Hesselmann, S; Schäfer, U; Bruns, F; Horst, E; Wilkowski, R; Assmann, G; Nolte, A; Diebold, J; Löhrs, U; Fritz, P; Hans-Jürgen, K; Mühlnickel, W; Bach, P; Wahlers, B; Kraus, HJ; Wulf, J; Hädinger, U; Baier, K; Krieger, T; Müller, G; Hof, H; Herfarth, K; Brunner, T; Hahn, SM; Schreiber, FS; Rustgi, AK; McKenna, WG; Bernhard, EJ; Guckenberger, M; Meyer, K; Willner, J; Schmidt, M; Kolb, M; Li, M; Gong, P; Abdollahi, A; Trinh, T; Huber, PE; Christiansen, H; Saile, B; Neubauer-Saile, K; Tippelt, S; Rave-Fränk, M; Hermann, RM; Dudas, J; Hess, CF; Schmidberger, H; Ramadori, G; Andratschke, N; Price, R; Ang, KK; Schwarz, S; Kulka, U; Busch ...
[Not Available].
Strahlenther Onkol. 2004; 180 Suppl 1:5-87
Doi: 10.1007/BF03356734
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB; Hahn, SM; McKenna, WG; Bernhard, EJ
Radiation Sensitization by inhibition of activated Ras
STRAHLENTHER ONKOL. 2004; 180(11): 731-740.
Doi: 10.1007/s00066-004-9198-8
Web of Science
PubMed
FullText
FullText_MUG
2003
Originalarbeit (Zeitschrift)
** Brunner, TB; Grabenbauer, GG; Klein, P; Baum, U; Papadopoulos, T; Bautz, W; Hohenberger, W; Sauer, R
Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.
Int J Radiat Oncol Biol Phys. 2003; 55(1):144-53
Doi: 10.1016/s0360-3016(02)03818-x
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, TB; Gupta, AK; Shi, Y; Hahn, SM; Muschel, RJ; Mckenna, WG; Bernhard, EJ
Farnesyltransferase inhibitors as radiation sensitizers
INT J RADIAT BIOL. 2003; 79(7): 569-576.
Doi: 10.1080/09553000310001610196
Web of Science
PubMed
FullText
FullText_MUG
** Fuchs, S; Rödel, C; Brunner, T; Iro, H; Niedobitek, G; Sauer, R; Grabenbauer, GG
Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
Onkologie. 2003; 26(1):12-8
Doi: 10.1159/000069858
Web of Science
PubMed
FullText
FullText_MUG
** Grabenbauer, GG; Rödel, C; Ernst-Stecken, A; Brunner, T; Hornung, J; Kittel, K; Steinhart, H; Iro, H; Sauer, R; Schultze-Mosgau, S
Neck dissection following radiochemotherapy of advanced head and neck cancer--for selected cases only?
Radiother Oncol. 2003; 66(1):57-63
Doi: 10.1016/s0167-8140(02)00193-7
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB; Hahn, SM; Gupta, AK; Muschel, RJ; McKenna, WG; Bernhard, EJ
Farnesyltransferase inhibitors: An overview of the results of preclinical and clinical investigations
CANCER RES. 2003; 63(18): 5656-5668.
Web of Science
PubMed
2001
Originalarbeit (Zeitschrift)
** Grabenbauer, GG; Rödel, C; Brunner, T; Schulze-Mosgau, S; Strnad, V; Müller, RG; Iro, H; Sauer, R
Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.
Strahlenther Onkol. 2001; 177(7):338-44
Doi: 10.1007/pl00002416
Web of Science
PubMed
FullText
FullText_MUG
2000
Originalarbeit (Zeitschrift)
** Brunner, TB; Grabenbauer, GG; Kastl, S; Herrmann, O; Baum, U; Fietkau, R; Klein, P; Bautz, W; Schneider, T; Hohenberger, W; Sauer, R
Preoperative Chemoradiation in Locally Advanced Pancreatic Carcinoma: A Phase II Study.
Onkologie. 2000; 23(5):436-442
Doi: 10.1159/000027214
Web of Science
PubMed
FullText
FullText_MUG
** Kastl, S; Brunner, T; Herrmann, O; Riepl, M; Fietkau, R; Grabenbauer, G; Sauer, R; Hohenberger, W; Klein, P
Neoadjuvant radio-chemotherapy in advanced primarilynon-resectable carcinomas of the pancreas.
Eur J Surg Oncol. 2000; 26(6):578-82
Doi: 10.1053/ejso.2000.0950
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Brunner, TB; Grabenbauer, GG; Baum, U; Hohenberger, W; Sauer, R
Adjuvant and neoadjuvant radiochemotherapy in ductal pancreatic carcinoma.
Strahlenther Onkol. 2000; 176(6):265-73
Doi: 10.1007/s000660050008
Web of Science
PubMed
FullText
FullText_MUG
1999
Originalarbeit (Zeitschrift)
** Baum, U; Lell, M; Nömayr, A; Wolf, H; Brunner, T; Greess, H; Bautz, W
[Multiplanar spiral CT in the diagnosis of pancreatic tumors].
Radiologe. 1999; 39(11):958-64
Doi: 10.1007/s001170050588
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, T
[Multimodality therapy of operable pancreatic cancer].
Strahlenther Onkol. 1999; 175(8):413-4
Web of Science
PubMed
1998
Originalarbeit (Zeitschrift)
** Grabenbauer, GG; Steininger, H; Meyer, M; Fietkau, R; Brunner, T; Heinkelmann, P; Hornung, J; Iro, H; Spitzer, W; Kirchner, T; Sauer, R; Distel, L
Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer.
Radiother Oncol. 1998; 47(2):175-83
Doi: 10.1016/s0167-8140(98)00016-4
Web of Science
PubMed
FullText
FullText_MUG